Original Article
Methicillin-Resistant S. aureus Infections among Patients in the Emergency Department
N Engl J Med 2006; 355:666-674August 17, 2006
- Abstract
Background
Methicillin-resistant Staphylococcus aureus (MRSA) is increasingly recognized in infections among persons in the community without established risk factors for MRSA.
Methods
We enrolled adult patients with acute, purulent skin and soft-tissue infections presenting to 11 university-affiliated emergency departments during the month of August 2004. Cultures were obtained, and clinical information was collected. Available S. aureus isolates were characterized by antimicrobial-susceptibility testing, pulsed-field gel electrophoresis, and detection of toxin genes. On MRSA isolates, we performed typing of the staphylococcal cassette chromosome mec (SCCmec), the genetic element that carries the mecA gene encoding methicillin resistance.
Results
S. aureus was isolated from 320 of 422 patients with skin and soft-tissue infections (76 percent). The prevalence of MRSA was 59 percent overall and ranged from 15 to 74 percent. Pulsed-field type USA300 isolates accounted for 97 percent of MRSA isolates; 74 percent of these were a single strain (USA300-0114). SCCmec type IV and the Panton–Valentine leukocidin toxin gene were detected in 98 percent of MRSA isolates. Other toxin genes were detected rarely. Among the MRSA isolates, 95 percent were susceptible to clindamycin, 6 percent to erythromycin, 60 percent to fluoroquinolones, 100 percent to rifampin and trimethoprim–sulfamethoxazole, and 92 percent to tetracycline. Antibiotic therapy was not concordant with the results of susceptibility testing in 100 of 175 patients with MRSA infection who received antibiotics (57 percent). Among methicillin-susceptible S. aureus isolates, 31 percent were USA300 and 42 percent contained pvl genes.
Conclusions
MRSA is the most common identifiable cause of skin and soft-tissue infections among patients presenting to emergency departments in 11 U.S. cities. When antimicrobial therapy is indicated for the treatment of skin and soft-tissue infections, clinicians should consider obtaining cultures and modifying empirical therapy to provide MRSA coverage.
Media in This Article
Table 1
Bacterial Isolates from Purulent Skin and Soft-Tissue Infections in 11 U.S. Emergency Departments.Table 2
Potential Risk Factors for Infection with MRSA, as Compared with Other Bacteria, in Patients with Purulent Skin and Soft-Tissue Infections in 11 U.S. Emergency Departments.Article Activity
- Article
Methicillin-resistant Staphylococcus aureus (MRSA) emerged in the 1960s as a cause of infection among patients exposed to the bacteria in health care settings.1 More recently, MRSA infections have been reported among persons without such exposure (community-associated MRSA).2,3 Community-associated outbreaks of MRSA infection have occurred among prisoners, intravenous-drug users, athletes, military trainees, and men who have sex with men.4-6 Community-associated MRSA has primarily been described as a cause of skin and soft-tissue infections, but it has also been associated with sepsis and necrotizing pneumonia.7-9 As compared with health care–associated MRSA isolates, community-associated MRSA isolates tend to be resistant to fewer antibiotics, to produce different toxins,10 and to have different types of the gene complex known as staphylococcal cassette chromosome mec (SCCmec); this complex contains the mecA gene that confers methicillin resistance.10 Pulsed-field gel electrophoresis (PFGE) and other methods have identified a small number of molecular types that have accounted for most community-associated MRSA isolates characterized in the United States.11
Some institutions have a high prevalence of MRSA isolated from patients with sporadic skin and soft-tissue infections that are not associated with an outbreak.12,13 However, data are limited regarding the prevalence of MRSA as a cause of skin and soft-tissue infections among patients in several communities throughout the United States and the S. aureus isolates associated with these infections. Therefore, we determined the prevalence of MRSA as a cause of skin infections among adult patients presenting to emergency departments in several geographically diverse, metropolitan areas in the United States. We also determined the bacteriologic characteristics of S. aureus isolated from skin and soft-tissue infections and evaluated factors potentially associated with MRSA infections of skin and soft tissue.
Methods
We conducted a prospective prevalence study involving adult patients with skin and soft-tissue infections who presented to hospitals in the EMERGEncy ID Net, a network of university-affiliated emergency departments in 11 U.S. cities: Albuquerque; Atlanta; Charlotte, N.C.; Kansas City, Mo.; Los Angeles; Minneapolis; New Orleans; New York; Philadelphia; Phoenix, Ariz.; and Portland, Oreg. These departments had a combined approximate total of 900,000 visits per year.14 The study was approved by the institutional review board at each site.
Patients 18 years of age or older presenting in August 2004 with purulent skin and soft-tissue infections of less than one week's duration (excluding perirectal abscesses) were enrolled in the study. Consent was obtained in writing at eight sites and orally with provision of an information sheet at three sites. Information on demographic characteristics, clinical presentation, potential risk factors for MRSA infection, and treatments provided was collected by emergency department physicians using standardized forms. Management decisions were made on an individual basis by physicians in the emergency department. Follow-up data were obtained by telephone approximately two to three weeks after enrollment.
Specimens were obtained from the single largest area of infection with the use of sterile Dacron swabs and were processed and cultured at hospital laboratories according to standard techniques.15 Each laboratory determined the antimicrobial susceptibility of S. aureus isolates to the panel of agents routinely tested at that laboratory.16 Available S. aureus isolates were forwarded to the Centers for Disease Control and Prevention (CDC) for further characterization. The inducibility of clindamycin resistance was determined by the D-zone disk-diffusion test.17 The presence of genes for staphylococcal enterotoxins A through E and H, toxic shock syndrome toxin 1 (TSST-1), and Panton–Valentine leukocidin (pvl) and the type of SCCmec were determined by the polymerase chain reaction. All isolates were typed by PFGE with the use of SmaI restriction endonuclease. Additional methods are described in detail in the Supplementary Appendix (available with the full text of this article at www.nejm.org).
Descriptive statistics were used to summarize the characteristics of the patients and the prevalence of MRSA. To identify potential risk factors for MRSA infection among patients with skin and soft-tissue infections, we calculated adjusted odds ratios and 95 percent confidence intervals. Variables associated with MRSA infection in bivariate analyses were explored further with the use of multivariate logistic regression.
Audits of emergency department and laboratory logs for patients with a discharge diagnosis of abscess, cellulitis, or wound infection were conducted at all study sites (except Atlanta) to determine the proportion of patients meeting eligibility criteria who were enrolled in the study. Demographic and clinical characteristics of enrolled patients were compared with those of unenrolled patients.
Results
A total of 422 patients with skin and soft-tissue infections were enrolled. The median age was 39 years (range, 18 to 79; interquartile range, 28 to 47), and 62 percent were men. Race or ethnic group was determined by the clinicians: 49 percent of patients were non-Hispanic blacks, 25 percent were non-Hispanic whites, 22 percent were Hispanic, and 4 percent belonged to other groups. Infections were located on the upper extremities in 29 percent of patients, lower extremities in 27 percent, torso in 17 percent, perineum in 14 percent, and head and neck in 13 percent. Infections were classified as an abscess in 81 percent of patients, an infected wound in 11 percent, and as cellulitis with purulent exudate in 8 percent.
S. aureus was isolated from skin and soft-tissue infections in 320 patients (76 percent); 249 of the S. aureus isolates (78 percent) were MRSA. MRSA was isolated from 59 percent of patients (Table 1Table 1
Bacterial Isolates from Purulent Skin and Soft-Tissue Infections in 11 U.S. Emergency Departments.). The prevalence of MRSA ranged from 15 to 74 percent, and MRSA was the most common identifiable cause of skin and soft-tissue infections in 10 of 11 emergency departments. MRSA was isolated from 61 percent of abscesses, 53 percent of purulent wounds, and 47 percent of cases of cellulitis with purulent exudate. Other organisms isolated from 1 percent or more of infections included 71 isolates of methicillin-susceptible S. aureus (MSSA) (17 percent); 30 isolates of streptococcus species (7 percent) including 6 group B streptococcus, 2 group A streptococcus, 3 non–group A and non–group B β-hemolytic streptococcus, 4 anaerobic or microaerophilic streptococcus, and 15 viridans group streptococcus; 12 isolates of coagulase-negative staphylococci (3 percent); and 6 isolates of Proteus mirabilis (1 percent). Cultures from 31 patients were polymicrobial; 10 of these patients had MRSA. No microorganism was isolated from 38 patients (9 percent).A total of 218 MRSA isolates (88 percent) and 55 MSSA isolates (77 percent) from 10 emergency departments were sent to the CDC for genetic and phenotypic characterization. The pulsed-field types of 216 of the MRSA isolates (99 percent) tested were characteristic of community-associated MRSA: 212 were type USA300, 2 were type USA400, and 2 were type USA1000.11,18 Of 212 MRSA isolates characterized as type USA300, 156 (74 percent) had a single pulsed-field pattern (strain USA300-0114). SCCmec type IV, characteristic of community-associated MRSA,19 was found in 214 (98 percent) of the MRSA isolates, and pvl toxin genes were present in 213 (98 percent). Genes for staphylococcal enterotoxins A, B, C, D, E, and H and TSST-1 were identified in five or fewer MRSA isolates. Eight S. aureus isolates collected at the Atlanta site in April 2005 were similar to other study isolates with regard to PFGE and toxin characteristics.
USA300 was also the most common pulsed-field type among MSSA isolates, accounting for 17 of 55 MSSA isolates (31 percent) sent to the CDC. Among these type USA300 isolates, 8 (47 percent) had a pulsed-field pattern closely related to that of the MRSA strain USA300-0114. In addition, pvl genes were detected in 23 MSSA isolates (42 percent), including 17 (100 percent) of the isolates characterized as USA300.
MRSA susceptibilities were as follows: 100 percent were susceptible to trimethoprim–sulfamethoxazole (217 of 217) and to rifampin (186 of 186); 95 percent were susceptible to clindamycin (215 of 226), 92 percent to tetracycline (207 of 226), 60 percent to fluoroquinolones (106 of 176), and 6 percent to erythromycin (13 of 226). Although the proportion of all S. aureus isolates (MRSA and MSSA) that were resistant to clindamycin was less than 15 percent at 10 of the study sites, 6 of 10 S. aureus isolates from New York City (60 percent) were resistant to clindamycin. Among the isolates that were sent to the CDC, 11 of 218 MRSA isolates (5 percent) and 7 of 55 MSSA isolates (13 percent) were not susceptible to clindamycin, including 4 (2 percent) MRSA isolates and 5 (9 percent) MSSA isolates with inducible clindamycin resistance detected by an antimicrobial-susceptibility D-zone disk-diffusion test. Sixty-six patients with MRSA infections (27 percent) had one or more established risk factors for health care–associated MRSA; these included 43 patients who had been hospitalized within the past year, 28 with a history of MRSA infection, 2 who resided in a long-term care facility, and 1 who was undergoing dialysis. Isolates from 55 of these patients were evaluated at the CDC, and 54 (98 percent) had pulsed-field types characteristic of community-associated MRSA.
Features associated with the isolation of MRSA as compared with the isolation of any other bacteria (Table 2Table 2
Potential Risk Factors for Infection with MRSA, as Compared with Other Bacteria, in Patients with Purulent Skin and Soft-Tissue Infections in 11 U.S. Emergency Departments.) included antibiotic use in the month before enrollment, the presence of an abscess or a lesion attributed to a spider bite at enrollment, history of MRSA infection, and a recent history of close contact with someone with a similar skin infection. The presence of an underlying illness and characterization as belonging to the “other” category of race or ethnic background were negatively associated with the isolation of MRSA. In multivariate logistic-regression analyses, all these factors were associated with MRSA infection, with the exception of the presence of an abscess (Table 3Table 3
Results of Multivariate Logistic-Regression Analyses to Identify Potential Risk Factors for MRSA Infection.). Black race was independently associated with MRSA infection. Controlling for study site did not affect the association between any of these factors and MRSA infection. Among 64 patients with none of these factors, 31 (48 percent) were infected with MRSA. The only factor that was significantly associated with isolation of MRSA, as compared with MSSA, was the presence of abscess at enrollment (odds ratio, 2.3; 95 percent confidence interval, 1.2 to 4.4).Complete information about treatment was available for 406 of the 422 patients (96 percent). Of these, 79 (19 percent) were treated with incision and drainage alone, 39 (10 percent) received antibiotics alone, 267 (66 percent) were treated with both incision and drainage and antibiotics, and 21 (5 percent) neither underwent incision and drainage nor received antibiotics. Of 400 patients for whom information about the outcome was available, 59 (15 percent) were admitted to the hospital. An antistaphylococcal penicillin or cephalosporin was given to 198 of 311 patients who received antibiotics (64 percent). In 100 of 175 MRSA infections for which antibiotic treatment was provided (57 percent), antibiotic therapy was not concordant with the results of susceptibility testing.
Of the 422 patients, 248 (59 percent) were contacted for follow-up 15 to 21 days (median, 17) after their visit to the emergency department, and 238 (96 percent) of those patients who were contacted for follow-up reported that their infection had resolved or improved. There were no significant differences in the outcome between patients infected with MRSA and those infected with other bacteria or between patients in whom the infecting MRSA isolate was resistant and those in whom the isolate was susceptible to the prescribed antibiotic. Baseline characteristics were similar for patients with and those without follow-up information.
Case-finding audits revealed that approximately 42 percent of eligible patients were enrolled. As compared with enrolled patients, unenrolled patients were similar in terms of age (mean, 38 years; range, 18 to 82), sex (63 percent were male), and race or ethnic group (57 percent were white non-Hispanic or Hispanic, 39 percent were black, and 4 percent were in other groups). MRSA was isolated in 135 of 236 eligible but unenrolled patients from whom wound cultures were obtained (57 percent).
Discussion
MRSA has emerged as the most common identifiable cause of skin and soft-tissue infections in several metropolitan areas across the United States. Although more than 80 percent of patients with skin and soft-tissue infections associated with MRSA in this study received empirical antimicrobial therapy for their infection, the infecting isolate was resistant to the agent prescribed for 57 percent of these patients. This finding suggests a need to reconsider empirical antimicrobial choices for skin and soft-tissue infections in areas where MRSA is prevalent in the community.
Our findings are consistent with the dramatic trend of increasing reports of outbreaks and increased prevalence of community-associated MRSA during the past few years. MRSA was uncommon in community-acquired skin and soft-tissue infections before 2000 and accounted for only 3 percent of staphylococcal isolates submitted to Minnesota laboratories in 2000.20 Between 2001 and 2004, the prevalence of MRSA among patients with skin and soft-tissue infections at our Los Angeles institution increased from 29 percent to 64 percent.13
Virtually all (99 percent) MRSA strains isolated from skin and soft-tissue infections in this study had pulsed-field types characteristic of community-associated MRSA, even though more than 25 percent of patients had established risk factors for health care–associated MRSA. A single pulsed-field type (USA300) accounted for 97 percent of MRSA isolates and 31 percent of MSSA isolates. A single strain (USA300-0114) associated with previously reported community outbreaks5 accounted for 72 percent of MRSA isolates, and a closely related strain was the single most common MSSA strain identified. Pulsed-field type USA300 has been linked to community-associated MRSA outbreaks throughout the country5,11 and represents the leading cause of community-associated MRSA in single-center prevalence studies.12,21 USA300 has rapidly replaced other pulsed-field types to become predominant among centers that have conducted longitudinal studies.22 Our finding of the genetic similarity of MRSA and MSSA isolates from community-associated infections is consistent with previous reports.7,8,21,23 This similarity suggests the acquisition of SCCmec by S. aureus strains established in the community or the loss of SCCmec by community-associated MRSA strains. The predominance of isolates from one genetic background may be related to virulence or transmissibility factors that confer unusual fitness.
Ninety-eight percent of MRSA isolates and more than 40 percent of MSSA isolates in our study contained pvl genes; these findings are consistent with other recent reports.24,25 S. aureus strains containing pvl genes have been associated with spontaneous skin and soft-tissue infections and necrotizing pneumonia; however, the role of pvl toxin in the pathogenesis of S. aureus skin and soft-tissue infections has not been fully elucidated.26
Most patients in our study were treated with β-lactam agents such as cephalexin and dicloxacillin, to which MRSA isolates are not susceptible. Although we had limited follow-up information, we found no association between patients' outcomes and the susceptibility of the pathogen to the prescribed antimicrobial agents. This absence of an association, which is consistent with previous reports,3,27 suggests that most simple skin abscesses, even when caused by MRSA, can be cured with adequate drainage alone. Nonetheless, when antibiotics are clinically indicated and MRSA is prevalent in the community, it is difficult to justify empirical use of agents known to be inactive against MRSA. The susceptibility of a given pathogen to prescribed antimicrobial agents may be more likely to affect the outcome among patients with cellulitis or purulent wounds. Unfortunately, there were insufficient numbers of these patients with follow-up information in our study to assess this relationship. Although we identified several clinical and epidemiologic factors associated with MRSA infection, it does not appear that the presence or absence of these factors would be useful to guide decisions about the use of empirical antibiotics. Most patients without MRSA had at least one of these factors, and almost half of those without any of these factors were found to have MRSA.
Various antimicrobial agents, such as clindamycin, trimethoprim–sulfamethoxazole, and doxycycline, have been recommended for outpatient empirical treatment of community-associated skin and soft-tissue infections that may be attributable to MRSA.28-30 More than 90 percent of MRSA isolates in our study were susceptible to each of these agents. Likewise, 100 percent of the MRSA isolates were susceptible to rifampin. Although resistance to rifampin monotherapy has occurred rapidly, the combination of rifampin plus trimethoprim–sulfamethoxazole has been shown to eradicate MRSA colonization and has been suggested for the treatment of MRSA infection in the community.31 Resistance to macrolides and fluoroquinolones was prevalent among MRSA isolates in this and other studies.3,12,13
Although the prevalence of clindamycin resistance, including inducible resistance, was low overall, it varied geographically. Clindamycin has been used successfully in the treatment of infections with MRSA isolates possessing inducible resistance.29,32 However, clinical treatment failures have also been reported.33 Therefore, if clindamycin therapy is being considered, S. aureus isolates with the potential for inducible clindamycin resistance (i.e., isolates resistant to erythromycin but susceptible to clindamycin on initial testing) should be evaluated for inducible resistance by D-zone disk-diffusion testing.17
Patients with nonpurulent cellulitis were not included in our study. Previous studies have shown that a large proportion of cellulitis may be attributable to group A streptococcus.34 In contrast, among infections characterized as cellulitis with purulent drainage in our study, MRSA was isolated from 47 percent and group A streptococcus was rarely isolated. Although generally susceptible in vitro to clindamycin, most group A streptococci are resistant to trimethoprim–sulfamethoxazole. To provide coverage for streptococcal infection, the use of clindamycin or a combination of a β-lactam plus trimethoprim–sulfamethoxazole may be preferable for nonpurulent cellulitis.
Optimal empirical therapy for severely ill hospitalized patients with complicated skin and soft-tissue infections has not been established; however, broad-spectrum intravenous therapy including an agent such as vancomycin for MRSA coverage remains appropriate. One study reported that clindamycin therapy was successful in children with invasive community-associated MRSA infections.29 In recent randomized clinical trials, newer agents with MRSA activity had efficacy similar (daptomycin and tigecycline) or superior (linezolid) to that of vancomycin for the treatment of complicated skin and soft-tissue infections or skin and soft-tissue infections associated with MRSA.35-37
As compared with patients with other bacterial infections of the skin, patients with MRSA infection were more likely to report a spider bite as the reason for their skin lesion, perhaps because of the propensity for MRSA strains circulating in the community to cause painful lesions in the absence of previous skin trauma. Thus, clinicians should consider the possibility of MRSA infection in patients who report spider bites. Eighteen percent of patients with skin and soft-tissue infections associated with MRSA reported close contact with a person who had a similar infection. This finding highlights the importance of educating patients about methods to prevent further transmission of infection, including keeping lesions covered with clean, dry bandages; practicing good hand hygiene; and avoiding the sharing of contaminated items.
The high prevalence of MRSA among patients with community-associated skin and soft-tissue infections has implications for hospital policies regarding infection control. Standard precautions (including the use of gowns and gloves by health care workers for contact with wound drainage) should be used for all patients. Contact precautions, which include the use of gowns and gloves for all contact with patients or their environment, have been recommended for patients in acute care inpatient facilities who are known to be infected or colonized with MRSA.38 Our results suggest that strategies used for patients with confirmed MRSA infections should be considered for all patients with purulent skin and soft-tissue infections in areas with a high prevalence of MRSA.
In many U.S. cities, MRSA is now the most common pathogen isolated in the emergency department from patients with skin and soft-tissue infections. Clinicians should consider obtaining cultures from patients with skin and soft-tissue infections and modifying standard empirical therapy to provide MRSA coverage when antibiotics are indicated. Further studies are needed to determine the extent of this infection in other locations, follow trends in antimicrobial susceptibility, and identify optimal therapy.
Supported by a cooperative agreement (U50/CCU912342) with the CDC.
The findings and conclusions of this report are those of the authors and do not necessarily represent the views of the funding agency.
Dr. Moran reports having received consulting fees from or having served on advisory boards for Schering-Plough and Pfizer; lecture fees from Schering-Plough, Pfizer, Aventis, and Cubist; and research support from Pfizer and Aventis. Dr. Talan reports having received consulting fees from or having served on advisory boards for Pfizer and Ortho-McNeil; lecture fees from Schering-Plough; and research support from Pfizer and Aventis. No other potential conflict of interest relevant to this article was reported.
We are indebted to Daniel Jernigan, Sigrid McAllister, Jean Patel, David Lonsway, George Killgore, Brandi Limbago, and Laura Jevitt at the CDC for providing technical and laboratory assistance; to the following site research coordinators: Ricky Amii, Cynthia Nguyen, Deborah Sibley, Mehr Merabodi, Carolyn Oakes, Marlena Wald, Tove Ryman, Yvonne Sanchez, Joni Kopitzke, Karen Pfaff, Sara Newton, Mary Mulrow, and Carol Von Hofen; and to the physicians at our study sites who assisted with data collection.
Source Information
From the Department of Emergency Medicine (G.J.M., A.K., D.A.T.) and the Division of Infectious Diseases (G.J.M., D.A.T.), Olive View–UCLA Medical Center, Sylmar, Calif.; and the Division of Healthcare Quality Promotion, National Center for Infectious Diseases, Centers for Disease Control and Prevention, Atlanta (R.J.G., G.E.F., L.K.M., R.B.C.).
Address reprint requests to Dr. Moran at the Department of Emergency Medicine, Olive View–UCLA Medical Center, 14445 Olive View Dr., North Annex, Sylmar, CA 91342, or at idnet@ucla.edu.
Members of the EMERGEncy ID Net Study Group are listed in the Appendix.
Appendix
The following investigators participated in the EMERGEncy ID Net Study Group: Olive View–University of California at Los Angeles Medical Center, Sylmar: F.M. Abrahamian; Hennepin County Medical Center, Minneapolis: M. Biros; University of New Mexico Health Sciences Center, Albuquerque: P.R. Cheney; Bellevue Hospital Center, New York: W.K. Chiang; Louisiana State University Health Science Center, New Orleans: L.M. Dunbar; Maricopa Medical Center, Phoenix, Ariz.: E. Gross; Emory University School of Medicine, Atlanta: K.L. Heilpern; Oregon Health Sciences University, Portland: J. Jui; Temple University School of Medicine, Philadelphia: D.J. Karras; University of Missouri–Kansas City, Kansas City: M.T. Steele; Carolinas Medical Center, Charlotte, N.C.: M. Sullivan.
- References
References
1
Barrett FF ,McGehee RF Jr ,Finland M . Methicillin-resistant Staphylococcus aureus at Boston City Hospital: bacteriologic and epidemiologic observations. N Engl J Med 1968;279:441-448
Full Text | Web of Science | Medline2
Herold BC ,Immergluck LC ,Maranan MC , et al. Community-acquired methicillin-resistant Staphylococcus aureus in children with no identified predisposing risk. JAMA 1998;279:593-598
CrossRef | Web of Science | Medline3
Fridkin SK ,Hageman JC ,Morrison M , et al. Methicillin-resistant Staphylococcus aureus disease in three communities. N Engl J Med 2005;352:1436-1444[Erratum, N Engl J Med 2005;352:2362.]
Full Text | Web of Science | Medline4
Outbreaks of community-associated methicillin-resistant Staphylococcus aureus skin infections -- Los Angeles County, California, 2002-2003. MMWR Morb Mortal Wkly Rep 2003;52:88-88
Medline5
Kazakova SV ,Hageman JC ,Matava M , et al. A clone of methicillin-resistant Staphylococcus aureus among professional football players. N Engl J Med 2005;352:468-475
Full Text | Web of Science | Medline6
Zinderman CE ,Conner B ,Malakooti MA ,LaMar JE ,Armstrong A ,Bohnker BK . Community-acquired methicillin-resistant Staphylococcus aureus among military recruits. Emerg Infect Dis 2004;10:941-944
Web of Science | Medline7
Gonzalez BE ,Martinez-Aguilar G ,Hulten KG , et al. Severe staphylococcal sepsis in adolescents in the era of community-acquired methicillin-resistant Staphylococcus aureus. Pediatrics 2005;115:642-648
CrossRef | Web of Science | Medline8
Mongkolrattanothai K ,Boyle S ,Kahana MD ,Daum RS . Severe Staphylococcus aureus infections caused by clonally related community-acquired methicillin-susceptible and methicillin-resistant isolates. Clin Infect Dis 2003;37:1050-1058
CrossRef | Web of Science | Medline9
Francis JS ,Doherty MC ,Lopatin U , et al. Severe community-onset pneumonia in healthy adults caused by methicillin-resistant Staphylococcus aureus carrying the Panton-Valentine leukocidin genes. Clin Infect Dis 2005;40:100-107
CrossRef | Web of Science | Medline10
Naimi TS ,LeDell KH ,Como-Sabetti K , et al. Comparison of community- and health care-associated methicillin-resistant Staphylococcus aureus infection. JAMA 2003;290:2976-2984
CrossRef | Web of Science | Medline11
McDougal LK ,Steward CD ,Killgore GE ,Chaitram JM ,McAllister SK ,Tenover FC . Pulsed-field gel electrophoresis typing of oxacillin-resistant Staphylococcus aureus isolates from the United States: establishing a national database. J Clin Microbiol 2003;41:5113-5120
CrossRef | Web of Science | Medline12
Frazee BW ,Lynn J ,Charlebois ED ,Lambert L ,Lowery D ,Perdreau-Remington F . High prevalence of methicillin-resistant Staphylococcus aureus in emergency department skin and soft tissue infections. Ann Emerg Med 2005;45:311-320
CrossRef | Web of Science | Medline13
Moran GJ ,Amii RN ,Abrahamian FM ,Talan DA . Methicillin-resistant Staphylococcus aureus in community-acquired skin infections. Emerg Infect Dis 2005;11:928-930
Web of Science | Medline14
Talan DA ,Moran GJ ,Mower W , et al. EMERGEncy ID NET: an emergency department-based emerging infections sentinel network. Ann Emerg Med 1998;32:703-711
CrossRef | Web of Science | Medline15
Bannerman TL. Staphylococci and other catalase positive cocci that grow aerobically. In: Murray PR, Baron EJ, Jogensen JH, eds. Manual of clinical microbiology. 8th ed. Washington, D.C.: ASM Press, 2003:384-404.
16
Performance standards for antimicrobial susceptibility testing: 14th informational supplement. M1000-S14. Wayne, Pa.: National Committee for Clinical Laboratory Standards, 2004.
17
Performance standards for antimicrobial susceptibility testing: 16th informational supplement. M100-S16. Wayne, Pa.: Clinical and Laboratory Standards Institute, 2006.
18
Pan ES ,Diep BA ,Charlebois ED , et al. Population dynamics of nasal strains of methicillin-resistant Staphylococcus aureus -- and their relation to community-associated disease activity. J Infect Dis 2005;192:811-818
CrossRef | Web of Science | Medline19
Daum RS ,Ito T ,Hiramatsu K , et al. A novel methicillin-resistance cassette in community-acquired methicillin-resistant Staphylococcus aureus isolates of diverse genetic backgrounds. J Infect Dis 2002;186:1344-1347
CrossRef | Web of Science | Medline20
Naimi TS ,LeDell KH ,Boxrud DJ , et al. Epidemiology and clonality of community-acquired methicillin-resistant Staphylococcus aureus in Minnesota, 1996-1998. Clin Infect Dis 2001;33:990-996
CrossRef | Web of Science | Medline21
Mishaan AM ,Mason EO Jr ,Martinez-Aguilar G , et al. Emergence of a predominant clone of community-acquired Staphylococcus aureus among children in Houston, Texas. Pediatr Infect Dis J 2005;24:201-206
CrossRef | Web of Science | Medline22
Chavez-Bueno S ,Bozdogan B ,Katz K , et al. Inducible clindamycin resistance and molecular epidemiologic trends of pediatric community-acquired methicillin-resistant Staphylococcus aureus in Dallas, Texas. Antimicrob Agents Chemother 2005;49:2283-2288
CrossRef | Web of Science | Medline23
Adem PV ,Montgomery CP ,Husain AN , et al. Staphylococcus aureus sepsis and the Waterhouse-Friderichsen syndrome in children. N Engl J Med 2005;353:1245-1251
Full Text | Web of Science | Medline24
Yamasaki O ,Kaneko J ,Morizane S , et al. The association between Staphylococcus aureus strains carrying Panton-Valentine leukocidin genes and the development of deep-seated follicular infection. Clin Infect Dis 2005;40:381-385
CrossRef | Web of Science | Medline25
Issartel B ,Tristan A ,Lechevallier S , et al. Frequent carriage of Panton-Valentine leucocidin genes by Staphylococcus aureus isolates from surgically drained abscesses. J Clin Microbiol 2005;43:3203-3207
CrossRef | Web of Science | Medline26
Lina G ,Piemont Y ,Godail-Gamot F , et al. Involvement of Panton-Valentine leukocidin-producing Staphylococcus aureus in primary skin infections and pneumonia. Clin Infect Dis 1999;29:1128-1132
CrossRef | Web of Science | Medline27
Lee MC ,Rios AM ,Aten MF , et al. Management and outcome of children with skin and soft tissue abscesses caused by community-acquired methicillin-resistant Staphylococcus aureus. Pediatr Infect Dis J 2004;23:123-127
CrossRef | Web of Science | Medline28
Kaplan SL . Treatment of community-associated methicillin-resistant Staphylococcus aureus infections. Pediatr Infect Dis J 2005;24:457-458
CrossRef | Web of Science | Medline29
Martinez-Aguilar G ,Hammerman WA ,Mason EO Jr ,Kaplan SL . Clindamycin treatment of invasive infections caused by community-acquired, methicillin-resistant and methicillin-susceptible Staphylococcus aureus in children. Pediatr Infect Dis J 2003;22:593-598
CrossRef | Web of Science | Medline30
Rybak MJ ,LaPlante KL . Community-associated methicillin-resistant Staphylococcus aureus: a review. Pharmacotherapy 2005;25:74-85
CrossRef | Web of Science | Medline31
Chambers HF . Treatment of infection and colonization caused by methicillin-resistant Staphylococcus aureus. Infect Control Hosp Epidemiol 1991;12:29-35
CrossRef | Web of Science | Medline32
Drinkovic D ,Fuller ER ,Shore KP ,Holland DJ ,Ellis-Pegler R . Clindamycin treatment of Staphylococcus aureus expressing inducible clindamycin resistance. J Antimicrob Chemother 2001;48:315-316
CrossRef | Web of Science | Medline33
Siberry GK ,Tekle T ,Carroll K ,Dick J . Failure of clindamycin treatment of methicillin-resistant Staphylococcus aureus expressing inducible clindamycin resistance in vitro. Clin Infect Dis 2003;37:1257-1260
CrossRef | Web of Science | Medline34
Bernard P ,Bedane C ,Mounier M ,Denis F ,Catanzano G ,Bonnetblanc JM . Streptococcal cause of erysipelas and cellulitis in adults: a microbiologic study using a direct immunofluorescence technique. Arch Dermatol 1989;125:779-782
CrossRef | Web of Science | Medline35
Weigelt J ,Itani K ,Stevens D , et al. Linezolid versus vancomycin in treatment of complicated skin and soft tissue infections. Antimicrob Agents Chemother 2005;49:2260-2266
CrossRef | Web of Science | Medline36
Carpenter CF ,Chambers HF . Daptomycin: another novel agent for treating infections due to drug-resistant gram-positive pathogens. Clin Infect Dis 2004;38:994-1000
CrossRef | Web of Science | Medline37
Nathwani D . Tigecycline: clinical evidence and formulary positioning. Int J Antimicrob Agents 2005;25:185-192
CrossRef | Web of Science | Medline38
Garner JS . Guidelines for isolation precautions in hospitals. Part I. Evolution of isolation practices. Am J Infect Control 1996;24:24-31
CrossRef | Web of Science | Medline
- Citing Articles (566)
Citing Articles
1
Miguel R Sanchez, Scott B Drutman. (2012) Current topics in infectious diseases of the skin. Expert Review of Dermatology 7:1, 93-106
CrossRef2
AH Shadyab, NF Crum-Cianflone. (2012) Methicillin-resistant Staphylococcus aureus (MRSA) infections among HIV-infected persons in the era of highly active antiretroviral therapy: a review of the literature. HIV Medicinen/a-n/a
CrossRef3
C. D. Paddock, L. Liu, A. M. Denison, J. H. Bartlett, R. C. Holman, M. DeLeon-Carnes, S. L. Emery, C. P. Drew, W.-J. Shieh, T. M. Uyeki, S. R. Zaki. (2012) Myocardial Injury and Bacterial Pneumonia Contribute to the Pathogenesis of Fatal Influenza B Virus Infection. Journal of Infectious Diseases
CrossRef4
C. Kebaier, R. R. Chamberland, I. C. Allen, X. Gao, P. M. Broglie, J. D. Hall, C. Jania, C. M. Doerschuk, S. L. Tilley, J. A. Duncan. (2012) Staphylococcus aureus -Hemolysin Mediates Virulence in a Murine Model of Severe Pneumonia Through Activation of the NLRP3 Inflammasome. Journal of Infectious Diseases
CrossRef5
S. Periasamy, H.-S. Joo, A. C. Duong, T.-H. L. Bach, V. Y. Tan, S. S. Chatterjee, G. Y. C. Cheung, M. Otto. (2012) How Staphylococcus aureus biofilms develop their characteristic structure. Proceedings of the National Academy of Sciences
CrossRef6
Zhiyang Feng, Debjani Chakraborty, Scott B. Dewell, Boojala Vijay B. Reddy, Sean F. Brady. (2012) Environmental DNA encoded antibiotics fasamycin A and B inhibit FabF in type II fatty-acid biosynthesis.. Journal of the American Chemical Society120105201441008
CrossRef7
Seung Sik Cho, Yun Hee Choi, Jaya Ram Simkhada, Poonam Mander, Da Jeong Park, Jin Cheol Yoo. (2012) A newly isolated Streptomyces sp. CS392 producing three antimicrobial compounds. Bioprocess and Biosystems Engineering 35:1-2, 247-254
CrossRef8
L. Tognetti, C. Martinelli, S. Berti, J. Hercogova, T. Lotti, F. Leoncini, S. Moretti. (2012) Bacterial skin and soft tissue infections: review of the epidemiology, microbiology, aetiopathogenesis and treatment. Journal of the European Academy of Dermatology and Venereologyno-no
CrossRef9
David J. Rosenberg. (2012) Infections, bacterial resistance, and antimicrobial stewardship: The emerging role of hospitalists. Journal of Hospital Medicine 7:S1, S34-S43
CrossRef10
Michael Z. David, Karen M. Rudolph, Thomas W. Hennessy, Diana L. Zychowski, Karthik Asthi, Susan Boyle-Vavra, Robert S. Daum. (2012) MRSA USA300 at Alaska Native Medical Center, Anchorage, Alaska, USA, 2000–2006. Emerging Infectious Diseases 18:1, 105-108
CrossRef11
Stefania Stefani, Doo Ryeon Chung, Jodi A. Lindsay, Alex W. Friedrich, Angela M. Kearns, Henrik Westh, Fiona M. MacKenzie. (2012) Meticillin-resistant Staphylococcus aureus (MRSA): global epidemiology and harmonisation of typing methods. International Journal of Antimicrobial Agents
CrossRef12
Beatriz Casado-Verrier, Cristina Gómez-Fernández, José Ramón Paño-Pardo, Rosa Gómez-Gil, Jesús Mingorance-Cruz, Ricardo Moreno-Alonso de Celada, Pedro Herranz-Pinto. (2012) Prevalencia de infecciones de piel y tejidos blandos producidas por Staphylococcus aureus resistente a Meticilina Comunitario en Madrid. Enfermedades Infecciosas y Microbiología Clínica
CrossRef13
R. Nazareth, J. Gonçalves-Pereira, A. Tavares, M. Miragaia, H. de Lencastre, J. Silvestre, P. Freitas, E. Gonçalves, F. Martins, V. Mendes, C. Tapadinhas, P. Póvoa. (2012) Infeção por staphylococcus aureus meticilina-resistente da comunidade em Portugal. Revista Portuguesa de Pneumologia (English Edition) 18:1, 34-38
CrossRef14
S. A. Fritz, P. G. Hogan, G. Hayek, K. A. Eisenstein, M. Rodriguez, E. K. Epplin, J. Garbutt, V. J. Fraser. (2011) Household Versus Individual Approaches to Eradication of Community-Associated Staphylococcus aureus in Children: A Randomized Trial. Clinical Infectious Diseases
CrossRef15
Y. Gillet, O. Dumitrescu, A. Tristan, O. Dauwalder, E. Javouhey, D. Floret, F. Vandenesch, J. Etienne, G. Lina. (2011) Pragmatic management of Panton–Valentine leukocidin-associated staphylococcal diseases. International Journal of Antimicrobial Agents 38:6, 457-464
CrossRef16
Jeffrey B. Travers, Amal Kozman, Yongxue Yao, Wenyu Ming, Weiguo Yao, Mathew J. Turner, Mark H. Kaplan, Nico Mousdicas, Anita N. Haggstrom, Chandan Saha. (2011) Treatment Outcomes of Secondarily Impetiginized Pediatric Atopic Dermatitis Lesions and the Role of Oral Antibiotics. Pediatric Dermatologyno-no
CrossRef17
Pascal Del Giudice, Pierre Tattevin, Jérôme Étienne. (2011) Infections à Staphylococcus aureus résistants à la méticilline communautaires. La Presse Médicale
CrossRef18
M. Morgan. (2011) Treatment of MRSA soft tissue infections: An overview. Injury 42, S11-S17
CrossRef19
Rodger Novak. (2011) Are pleuromutilin antibiotics finally fit for human use?. Annals of the New York Academy of Sciences 1241:1, 71-81
CrossRef20
A. M. Rivera, H. W. Boucher. (2011) Current Concepts in Antimicrobial Therapy Against Select Gram-Positive Organisms: Methicillin-Resistant Staphylococcus aureus, Penicillin-Resistant Pneumococci, and Vancomycin-Resistant Enterococci. Mayo Clinic Proceedings 86:12, 1230-1243
CrossRef21
Richard R. Drake, Sarah R. Boggs, Steven K. Drake. (2011) Pathogen identification using mass spectrometry in the clinical microbiology laboratory. Journal of Mass Spectrometry 46:12, 1223-1232
CrossRef22
Dawn M. Sievert, Matthew L. Boulton, Mark L. Wilson, Melinda J. Wilkins, Brenda W. Gillespie. (2011) A Multivariable Model to Classify Methicillin-Resistant Staphylococcus aureus Infections as Health Care or Community Associated. Infectious Diseases in Clinical Practice1
CrossRef23
Jean-Baptiste Ricco, Ojan Assadian. (2011) Antimicrobial Silver Grafts for Prevention and Treatment of Vascular Graft Infection. Seminars in Vascular Surgery 24:4, 234-241
CrossRef24
Mark G. Parker, Bradley N. Doebbeling. (2011) The Challenge of Methicillin-Resistant Staphylococcus aureus Prevention in Hemodialysis Therapy. Seminars in Dialysisno-no
CrossRef25
Sheila Krishna, Lloyd S Miller. (2011) Host–pathogen interactions between the skin and Staphylococcus aureus. Current Opinion in Microbiology
CrossRef26
Michele C. Jen, María C. Serrano, Robert van Lith, Guillermo A. Ameer. (2011) Polymer-Based Nitric Oxide Therapies: Recent Insights for Biomedical Applications. Advanced Functional Materialsn/a-n/a
CrossRef27
Bonggoo Park, George Y. Liu. (2011) Targeting the host–pathogen interface for treatment of Staphylococcus aureus infection. Seminars in Immunopathology
CrossRef28
Brad Spellberg, Robert Daum. (2011) Development of a vaccine against Staphylococcus aureus. Seminars in Immunopathology
CrossRef29
Kevin M. Rigby, Frank R. DeLeo. (2011) Neutrophils in innate host defense against Staphylococcus aureus infections. Seminars in Immunopathology
CrossRef30
Sheila Krishna, Lloyd S. Miller. (2011) Innate and adaptive immune responses against Staphylococcus aureus skin infections. Seminars in Immunopathology
CrossRef31
James E. Cassat, Eric P. Skaar. (2011) Metal ion acquisition in Staphylococcus aureus: overcoming nutritional immunity. Seminars in Immunopathology
CrossRef32
Nancy F. Crum-Cianflone, Aladdin H. Shadyab, Amy Weintrob, Duane R. Hospenthal, Tahaniyat Lalani, Gary Collins, Alona Mask, Katrin Mende, Stephanie K. Brodine, Brian K. Agan. (2011) Association of Methicillin-Resistant Staphylococcus aureus (MRSA) Colonization With High-Risk Sexual Behaviors in Persons Infected With Human Immunodeficiency Virus (HIV). Medicine 90:6, 379-389
CrossRef33
J.A. Otter, G.L. French. (2011) Community-associated meticillin-resistant Staphylococcus aureus strains as a cause of healthcare-associated infection. Journal of Hospital Infection 79:3, 189-193
CrossRef34
A. M. Milstone, B. W. Goldner, T. Ross, J. W. Shepard, K. C. Carroll, T. M. Perl. (2011) Methicillin-Resistant Staphylococcus aureus Colonization and Risk of Subsequent Infection in Critically Ill Children: Importance of Preventing Nosocomial Methicillin-Resistant Staphylococcus aureus Transmission. Clinical Infectious Diseases 53:9, 853-859
CrossRef35
Jeffrey Ross Suchard. (2011) “Spider Bite” Lesions are Usually Diagnosed as Skin and Soft-Tissue Infections. The Journal of Emergency Medicine 41:5, 473-481
CrossRef36
Michael W. Sauer, Daniel A. Hirsh, Harold K. Simon, Shervin A. Kharazmi, Jesse J. Sturm. (2011) Pediatric abscess characteristics associated with hospital admission from the ED. The American Journal of Emergency Medicine 29:9, 1013-1018
CrossRef37
Jessica M. Nerby, Rachel Gorwitz, Lindsey Lesher, Billie Juni, Selina Jawahir, Ruth Lynfield, Kathleen Harriman. (2011) Risk Factors for Household Transmission of Community-associated Methicillin-resistant Staphylococcus aureus. The Pediatric Infectious Disease Journal 30:11, 927-932
CrossRef38
José M. Marimón, María Villar, José M. García-Arenzana, Idoia de la Caba, Emilio Pérez-Trallero. (2011) Molecular characterization of Staphylococcus aureus carrying the panton-valentine leucocidin genes in northern Spain. Journal of Infection
CrossRef39
Nisha Nair, Ekaterina Kourbatova, Katharine Poole, Charmaine M. Huckabee, Patrick Murray, W. Charles Huskins, Henry M. Blumberg. (2011) Molecular Epidemiology of Methicillin-Resistant Staphylococcus aureus (MRSA) among Patients Admitted to Adult Intensive Care Units: The STAR*ICU Trial. Infection Control and Hospital Epidemiology 32:11, 1057-1063
CrossRef40
Pamela J. Yeh, Dawn M. Simon, Jess A. Millar, H. Forrest Alexander, Darleen Franklin. (2011) A diversity of Antibiotic-resistant Staphylococcus spp. in a Public Transportation System. Osong Public Health and Research Perspectives
CrossRef41
Craig G. Gunderson, Richard A. Martinello. (2011) A systematic review of bacteremias in cellulitis and erysipelas. Journal of Infection
CrossRef42
Adam Weiss, Peter Nelson, Reza Movahed, Earl Clarkson, Harry Dym. (2011) Necrotizing Fasciitis: Review of the Literature and Case Report. Journal of Oral and Maxillofacial Surgery 69:11, 2786-2794
CrossRef43
B. Hota, R. Lyles, J. Rim, K. J. Popovich, T. Rice, A. Aroutcheva, R. A. Weinstein, . (2011) Predictors of Clinical Virulence in Community-Onset Methicillin-Resistant Staphylococcus aureus Infections: The Importance of USA300 and Pneumonia. Clinical Infectious Diseases 53:8, 757-765
CrossRef44
P. Peyrani, M. Allen, T. L. Wiemken, N. Z. Haque, M. J. Zervos, K. D. Ford, E. G. Scerpella, J. E. Mangino, D. H. Kett, J. A. Ramirez, . (2011) Severity of Disease and Clinical Outcomes in Patients With Hospital-Acquired Pneumonia Due to Methicillin-Resistant Staphylococcus aureus Strains Not Influenced by the Presence of the Panton-Valentine Leukocidin Gene. Clinical Infectious Diseases 53:8, 766-771
CrossRef45
, B. Lamy, F. Laurent, O. Gallon, F. Doucet-Populaire, J. Etienne, J.-W. Decousser. (2011) Antibacterial resistance, genes encoding toxins and genetic background among Staphylococcus aureus isolated from community-acquired skin and soft tissue infections in France: a national prospective survey. European Journal of Clinical Microbiology & Infectious Diseases
CrossRef46
S. Pichereau, J. J. M. Moran, M. S. Hayney, S. K. Shukla, G. Sakoulas, W. E. Rose. (2011) Concentration-dependent effects of antimicrobials on Staphylococcus aureus toxin-mediated cytokine production from peripheral blood mononuclear cells. Journal of Antimicrobial Chemotherapy
CrossRef47
Timothy P. Young, Lee Maas, Andrea W. Thorp, Lance Brown. (2011) Etiology of septic arthritis in children: an update for the new millennium. The American Journal of Emergency Medicine 29:8, 899-902
CrossRef48
Rajesh K. Aneja, Ruby Varughese-Aneja, Carol G. Vetterly, Joseph A. Carcillo. (2011) Antibiotic Therapy in Neonatal and Pediatric Septic Shock. Current Infectious Disease Reports 13:5, 433-441
CrossRef49
Aurore Caillault-Sergent, Julien Illinger, Olivier Dauwalder, Pascale Nesme, Laurent Argaud. (2011) Pneumonie communautaire nécrosante à Staphylococcus aureus sécréteur de la leucocidine de Panton-Valentine : un diagnostic rare auquel il faut penser. La Presse Médicale 40:10, 966-970
CrossRef50
E. Mostofsky, M. Lipsitch, G. Regev-Yochay. (2011) Is methicillin-resistant Staphylococcus aureus replacing methicillin-susceptible S. aureus?. Journal of Antimicrobial Chemotherapy 66:10, 2199-2214
CrossRef51
Luke F. Chen, Cody Chastain, Deverick J. Anderson. (2011) Community-Acquired Methicillin-Resistant Staphylococcus aureus Skin and Soft Tissue Infections: Management and Prevention. Current Infectious Disease Reports 13:5, 442-450
CrossRef52
Deena E. Sutter, Amy M. Summers, Christine E. Keys, Kimberly L. Taylor, Carl E. Frasch, LoRanee E. Braun, Ali I. Fattom, Margaret C. Bash. (2011) Capsular serotype of Staphylococcus aureus in the era of community-acquired MRSA. FEMS Immunology & Medical Microbiology 63:1, 16-24
CrossRef53
Craig G. Gunderson. (2011) Cellulitis: Definition, Etiology, and Clinical Features. The American Journal of Medicine
CrossRef54
Annelise L. Dawson, Robert P. Dellavalle, Dirk M. Elston. (2011) Infectious Skin Diseases: A Review and Needs Assessment. Dermatologic Clinics
CrossRef55
Tamsin R. Sheen, Courtney K. Cavaco, Celia M. Ebrahimi, Marilyn L. Thoman, Sam D. Sanderson, Edward L. Morgan, Kelly S. Doran. (2011) Control of methicillin resistant Staphylococcus aureus infection utilizing a novel immunostimulatory peptide. Vaccine
CrossRef56
S. D. Kobayashi, N. Malachowa, A. R. Whitney, K. R. Braughton, D. J. Gardner, D. Long, J. B. Wardenburg, O. Schneewind, M. Otto, F. R. DeLeo. (2011) Comparative Analysis of USA300 Virulence Determinants in a Rabbit Model of Skin and Soft Tissue Infection. Journal of Infectious Diseases 204:6, 937-941
CrossRef57
Paolo Boscolo-Rizzo, Marco Stellin, Enrico Muzzi, Monica Mantovani, Roberto Fuson, Valentina Lupato, Franco Trabalzini, Maria Cristina Mosto. (2011) Deep neck infections: a study of 365 cases highlighting recommendations for management and treatment. European Archives of Oto-Rhino-Laryngology
CrossRef58
Marisa A. Earley, Mark E. Friedel, Satish Govindaraj, Belachew Tessema, Jean Anderson Eloy. (2011) Community-acquired methicillin-resistant Staphylococcus aureus in nasal vestibular abscess. International Forum of Allergy & Rhinology 1:5, 379-381
CrossRef59
Christopher J. Graber, Andi L. Shane, Peggy Weintrub, Henry F. Chambers. (2011) Clonality of Staphylococcus aureus Colonization over Time in Attendees of a Camp for Children with Chronic Dermatoses. Pediatric Dermatology 28:5, 519-523
CrossRef60
Natalie Shilo, Caroline Quach. (2011) Pulmonary Infections and Community Associated Methicillin Resistant Staphylococcus Aureus: A Dangerous Mix?. Paediatric Respiratory Reviews 12:3, 182-189
CrossRef61
Jeffrey S. Ustin, Mark A. Malangoni. (2011) Necrotizing soft-tissue infections. Critical Care Medicine 39:9, 2156-2162
CrossRef62
Tzu-Chun Lin, Cheng-Huang Chang, Song-Jen Hong, Yeong-Chuan Tsai, Chung-Hsing Chang. (2011) Methicillin-resistant Staphylococcus aureus in skin and soft tissue infections and minocyclin treatment experience in the dermatological setting of eastern Taiwan. Dermatologica Sinica 29:3, 86-90
CrossRef63
Gillian R. Schmitz. (2011) How Do You Treat an Abscess in the Era of Increased Community-associated Methicillin-resistant Staphylococcus Aureus (MRSA)?. The Journal of Emergency Medicine 41:3, 276-281
CrossRef64
A. Vergison, A. Nobre Machado, A. Deplano, M. Doyen, J. Brauner, C. Nonhoff, R. de Mendonça, G. Mascart, O. Denis. (2011) Heterogeneity of disease and clones of community-onset methicillin-resistant Staphylococcus aureus in children attending a paediatric hospital in Belgium. Clinical Microbiology and Infectionno-no
CrossRef65
Michael P. Phelan, Jean P. Schils, Daniel Burval, Carlos M. Isada. (2011) Methicillin-Resistant Staphyloccocus Aureus Heel Abscess: An Uncommon Emergency Department Diagnosis. The Journal of Emergency Medicine 41:3, e55-e58
CrossRef66
E. J. Septimus, R. C. Owens. (2011) Need and Potential of Antimicrobial Stewardship in Community Hospitals. Clinical Infectious Diseases 53:suppl 1, S8-S14
CrossRef67
Shih-Hsun Shen, Kuo-Chin Huang, Chin-Chang Cheng, Tsung-Jen Huang, Robert Wen-Wei Hsu, Yao-Hung Tsai. (2011) Monomicrobial necrotizing fasciitis caused by coagulase-negative Staphylococci and methicillin-resistant Staphylococcus aureus. European Journal of Orthopaedic Surgery & Traumatology
CrossRef68
Jina Lee, Ji Yeon Sung, Young Min Kim, Chi Eun Oh, Hong Bin Kim, Eun Hwa Choi, Hoan Jong Lee. (2011) Molecular characterization of methicillin-resistant Staphylococcus aureus obtained from the anterior nares of healthy Korean children attending daycare centers. International Journal of Infectious Diseases 15:8, e558-e563
CrossRef69
Daniel P. Uccello, Shawn M. Miller, Noah A. Dieterich, Antonia F. Stepan, SeungWon Chung, Kathleen A. Farley, Brian Samas, Jinshan Chen, Justin I. Montgomery. (2011) The synthesis of C-13 functionalized pleuromutilins via C–H amidation and subsequent novel rearrangement product. Tetrahedron Letters 52:33, 4247-4251
CrossRef70
M. Dalager-Pedersen, M. Søgaard, H. C. Schønheyder. (2011) Staphylococcus aureus skin and soft tissue infections in primary healthcare in Denmark: a 12-year population-based study. European Journal of Clinical Microbiology & Infectious Diseases 30:8, 951-956
CrossRef71
Barbara M. Bröker, Alex van Belkum. (2011) Immune proteomics of Staphylococcus aureus. PROTEOMICS 11:15, 3221-3231
CrossRef72
A.-C. Uhlemann, C. Dumortier, C. Hafer, B. S. Taylor, J. Sánchez E., C. Rodriguez-Taveras, P. Leon, R. Rojas, C. Olive, F. D. Lowy. (2011) Molecular characterization of Staphylococcus aureus from outpatients in the Caribbean reveals the presence of pandemic clones. European Journal of Clinical Microbiology & Infectious Diseases
CrossRef73
Trevor Van Schooneveld, Md. (2011) Antimicrobial stewardship: attempting to preserve a strategic resource. Journal of Community Hospital Internal Medicine Perspectives 1:2,
CrossRef74
S. M. SHURLAND, O. C. STINE, R. A. VENEZIA, M. ZHAN, J. P. FURUNO, R. R. MILLER, M.-C. ROGHMANN. (2011) USA300 methicillin-resistant S. aureus (USA300 MRSA) colonization and the risk of MRSA infection in residents of extended-care facilities. Epidemiology and Infection1-10
CrossRef75
D. A. Talan, A. Krishnadasan, R. J. Gorwitz, G. E. Fosheim, B. Limbago, V. Albrecht, G. J. Moran, . (2011) Comparison of Staphylococcus aureus From Skin and Soft-Tissue Infections in US Emergency Department Patients, 2004 and 2008. Clinical Infectious Diseases 53:2, 144-149
CrossRef76
Bradley W. Frazee, Jahan Fahimi, Larry Lambert, Arun Nagdev. (2011) Emergency Department Ultrasonographic Probe Contamination and Experimental Model of Probe Disinfection. Annals of Emergency Medicine 58:1, 56-63
CrossRef77
P. J. PETERS, J. T. BROOKS, B. LIMBAGO, H. K. LOWERY, S. K. McALLISTER, R. MINDLEY, G. FOSHEIM, R. J. GORWITZ, J. L. GUEST, J. HAGEMAN, J. FRIDGE, D. RIMLAND. (2011) Methicillin-resistant Staphylococcus aureus colonization in HIV-infected outpatients is common and detection is enhanced by groin culture. Epidemiology and Infection 139:07, 998-1008
CrossRef78
Mark Bounthavong, Amir Zargarzadeh, Donald I. Hsu, David J. Vanness. (2011) Cost-Effectiveness Analysis of Linezolid, Daptomycin, and Vancomycin in Methicillin-Resistant Staphylococcus aureus: Complicated Skin and Skin Structure Infection Using Bayesian Methods for Evidence Synthesis. Value in Health 14:5, 631-639
CrossRef79
Larissa May, Chad Porter, David Tribble, Adam Armstrong, Manal Mostafa, Mark Riddle. (2011) Self-reported incidence of skin and soft tissue infections among deployed US military. Travel Medicine and Infectious Disease 9:4, 213-220
CrossRef80
J. KIM, C. FERRATO, G. R. GOLDING, M. R. MULVEY, K. A. SIMMONDS, L. W. SVENSON, G. KEAYS, L. CHUI, M. LOVGREN, M. LOUIE. (2011) Changing epidemiology of methicillin-resistant Staphylococcus aureus in Alberta, Canada: population-based surveillance, 2005–2008. Epidemiology and Infection 139:07, 1009-1018
CrossRef81
Bernard Friedman, Terceira Berdahl, Lisa A. Simpson, Marie C. McCormick, Pamela L. Owens, Roxanne Andrews, Patrick S. Romano. (2011) Annual Report on Health Care for Children and Youth in the United States: Focus on Trends in Hospital Use and Quality. Academic Pediatrics 11:4, 263-279
CrossRef82
Lloyd S. Miller, John S. Cho. (2011) Immunity against Staphylococcus aureus cutaneous infections. Nature Reviews Immunology 11:8, 505-518
CrossRef83
R. Nazareth, J. Gonçalves-Pereira, A. Tavares, M. Miragai, H. de Lencastre, J. Silvestre, P. Freitas, E. Gonçalves, F. Martins, V. Mendes, C. Tapadinhas, P. Póvoa. (2011) Community-associated methicillin-resistant Staphylococcus aureus infection in Portugal. Revista Portuguesa de Pneumologia
CrossRef84
D. Mithoe, M. I. A. Rijnders, B. M. Roede, E. Stobberingh, A. V. M. Möller. (2011) Prevalence of community-associated meticillin-resistant Staphylococcus aureus and Panton–Valentine leucocidin-positive S. aureus in general practice patients with skin and soft tissue infections in the northern and southern regions of The Netherlands. European Journal of Clinical Microbiology & Infectious Diseases
CrossRef85
R. C. Moellering, G. R. Corey, M. L. Grayson. (2011) Introduction: Fusidic Acid Enters the United States. Clinical Infectious Diseases 52:Supplement 7, S467-S468
CrossRef86
Robertino M. Mera, Jose A. Suaya, Heather Amrine-Madsen, Cosmina S. Hogea, Linda A. Miller, Emily P. Lu, Daniel F. Sahm, Patrick O'Hara, Camilo J. Acosta. (2011) Increasing Role of Staphylococcus aureus and Community-Acquired Methicillin-Resistant Staphylococcus aureus Infections in the United States: A 10-Year Trend of Replacement and Expansion. Microbial Drug Resistance 17:2, 321-328
CrossRef87
Jeanette M. Daly, John W. Ely, Barcey T. Levy, Tara C. Smith, Mary L. Merchant, George R. Bergus, Gerald J. Jogerst. (2011) Primary Care Clinicians’ Perspectives on Management of Skin and Soft Tissue Infections: An Iowa Research Network Study. The Journal of Rural Health 27:3, 319-328
CrossRef88
Miriam García-Arias, Alejandro Balsa, Emilio Martín Mola. (2011) Septic arthritis. Best Practice & Research Clinical Rheumatology 25:3, 407-421
CrossRef89
J. G. Still, K. Clark, T. P. Degenhardt, D. Scott, P. Fernandes, M. J. Gutierrez. (2011) Pharmacokinetics and Safety of Single, Multiple, and Loading Doses of Fusidic Acid in Healthy Subjects. Clinical Infectious Diseases 52:Supplement 7, S504-S512
CrossRef90
Alexandra Balma-Mena, Irene Lara-Corrales, Jeanne Zeller, Susan Richardson, Martin J. McGavin, Miriam Weinstein, Elena Pope. (2011) Colonization with community-acquired methicillin-resistant Staphylococcus aureus in children with atopic dermatitis: a cross-sectional study. International Journal of Dermatology 50:6, 682-688
CrossRef91
Nathan D. Schwalm, Bindhu Verghese, Stephen J. Knabel. (2011) A novel multiplex PCR method for detecting the major clonal complexes of MRSA in nasal isolates from a Pennsylvania hospital. Journal of Microbiological Methods
CrossRef92
J. C. Craft, S. R. Moriarty, K. Clark, D. Scott, T. P. Degenhardt, J. G. Still, G. R. Corey, A. Das, P. Fernandes. (2011) A Randomized, Double-Blind Phase 2 Study Comparing the Efficacy and Safety of an Oral Fusidic Acid Loading-Dose Regimen to Oral Linezolid for the Treatment of Acute Bacterial Skin and Skin Structure Infections. Clinical Infectious Diseases 52:Supplement 7, S520-S526
CrossRef93
G. R. Corey, M. E. Stryjewski. (2011) New Rules for Clinical Trials of Patients With Acute Bacterial Skin and Skin-Structure Infections: Do Not Let the Perfect Be the Enemy of the Good. Clinical Infectious Diseases 52:Supplement 7, S469-S476
CrossRef94
V. L. Vaska, G. R. Nimmo, M. Jones, K. Grimwood, D. L. Paterson. (2011) Increases in Australian cutaneous abscess hospitalisations: 1999–2008. European Journal of Clinical Microbiology & Infectious Diseases
CrossRef95
Adam J. Singer, Henry C. Thode, Stuart Chale, Breena R. Taira, Christopher Lee. (2011) Primary closure of cutaneous abscesses: a systematic review. The American Journal of Emergency Medicine 29:4, 361-366
CrossRef96
Elissa M. Schechter-Perkins, Patricia M. Mitchell, Kate A. Murray, Julia E. Rubin-Smith, Susan Weir, Kalpana Gupta. (2011) Prevalence and Predictors of Nasal and Extranasal Staphylococcal Colonization in Patients Presenting to the Emergency Department. Annals of Emergency Medicine 57:5, 492-499
CrossRef97
(2011) Combating Antimicrobial Resistance: Policy Recommendations to Save Lives. Clinical Infectious Diseases 52:Supplement 5, S397-S428
CrossRef98
A. P. Johnson. (2011) Methicillin-resistant Staphylococcus aureus: the European landscape. Journal of Antimicrobial Chemotherapy 66:Supplement 4, iv43-iv48
CrossRef99
Romolo J. Gaspari, Dana Resop, Michelle Mendoza, Tarina Kang, David Blehar. (2011) A Randomized Controlled Trial of Incision and Drainage Versus Ultrasonographically Guided Needle Aspiration for Skin Abscesses and the Effect of Methicillin-Resistant Staphylococcus aureus. Annals of Emergency Medicine 57:5, 483-491.e1
CrossRef100
Vladimir Lazarevic, Marie Beaume, Anna Corvaglia, David Hernandez, Jacques Schrenzel, Patrice François. (2011) Epidemiology and virulence insights from MRSA and MSSA genome analysis. Future Microbiology 6:5, 513-532
CrossRef101
Paul Drinka, Phyllis Bonham, Christopher J. Crnich. (2011) Swab Culture of Purulent Skin Infection to Detect Infection or Colonization With Antibiotic-Resistant Bacteria. Journal of the American Medical Directors Association
CrossRef102
S. J. EELLS, S. CHIRA, C. G. DAVID, N. CRAFT, L. G. MILLER. (2011) Non-suppurative cellulitis: risk factors and its association with Staphylococcus aureus colonization in an area of endemic community-associated methicillin-resistant S. aureus infections. Epidemiology and Infection 139:04, 606-612
CrossRef103
Carla J. Walraven, Erin Lingenfelter, Jeannie Rollo, Troy Madsen, Donald P. Alexander. (2011) Diagnostic and Therapeutic Evaluation of Community-acquired Methicillin-resistant Staphylococcus Aureus (MRSA) Skin and Soft Tissue Infections in the Emergency Department. The Journal of Emergency Medicine
CrossRef104
K. S. Ko, S.-K. Lim, S.-C. Jung, J. M. Yoon, J. Y. Choi, J.-H. Song. (2011) Sequence type 72 meticillin-resistant Staphylococcus aureus isolates from humans, raw meat and soil in South Korea. Journal of Medical Microbiology 60:4, 442-445
CrossRef105
K. Antri, N. Rouzic, O. Dauwalder, I. Boubekri, M. Bes, G. Lina, F. Vandenesch, M. Tazir, N. Ramdani-Bouguessa, J. Etienne. (2011) High prevalence of methicillin-resistant Staphylococcus aureus clone ST80-IV in hospital and community settings in Algiers. Clinical Microbiology and Infection 17:4, 526-532
CrossRef106
Wen-Tsung Lo, Chih-Chien Wang. (2011) Panton-Valentine Leukocidin in the Pathogenesis of Community-associated Methicillin-resistant Staphylococcus aureus Infection. Pediatrics & Neonatology 52:2, 59-65
CrossRef107
Michael Otto. (2011) Panton–Valentine leukocidin antibodies for the treatment of MRSA skin infections?. Expert Review of Anti-infective Therapy 9:4, 389-392
CrossRef108
John S Cho, Jamie Zussman, Niles P Donegan, Romela Irene Ramos, Nairy C Garcia, Daniel Z Uslan, Yoichiro Iwakura, Scott I Simon, Ambrose L Cheung, Robert L Modlin, Jenny Kim, Lloyd S Miller. (2011) Noninvasive In Vivo Imaging to Evaluate Immune Responses and Antimicrobial Therapy against Staphylococcus aureus and USA300 MRSA Skin Infections. Journal of Investigative Dermatology 131:4, 907-915
CrossRef109
Roderick Hay, Noorlaily Mohd Noor. (2011) Panton–Valentine leucocidin and severe Staphylococcus aureus infections of the skin: sole culprit or does it have accomplices?. Current Opinion in Infectious Diseases 24:2, 97-99
CrossRef110
Andie S. Lee, Benedikt Huttner, Stephan Harbarth. (2011) Control of Methicillin-resistant Staphylococcus aureus. Infectious Disease Clinics of North America 25:1, 155-179
CrossRef111
Melissa M. Gaver-Wainwright, Richard S. Zack, Matthew J. Foradori, Laura Corley Lavine. (2011) Misdiagnosis of Spider Bites: Bacterial Associates, Mechanical Pathogen Transfer, and Hemolytic Potential of Venom from the Hobo Spider, Tegenaria agrestis (Araneae: Agelenidae). Journal of Medical Entomology 48:2, 382-388
CrossRef112
William F. McNamara, Charles W. Hartin, Mauricio A. Escobar, Sani Z. Yamout, Stanley T. Lau, Yi-Horng Lee. (2011) An alternative to open incision and drainage for community-acquired soft tissue abscesses in children. Journal of Pediatric Surgery 46:3, 502-506
CrossRef113
Jonathan A. Otter, Catherine L. Passaretti, Gary L. French, Tracy Ross, Karen C. Carroll, Trish M. Perl. (2011) Low frequency of environmental contamination with methicillin-resistant Staphylococcus aureus in an inner city emergency department and a human immunodeficiency virus outpatient clinic. American Journal of Infection Control 39:2, 151-153
CrossRef114
Christelle Kassis, Ray Hachem, Issam I. Raad, Cheryl A. Perego, Tanya Dvorak, Kristina G. Hulten, Elizabeth Frenzel, Georgia Thomas, Roy F. Chemaly. (2011) Outbreak of community-acquired methicillin-resistant Staphylococcus aureus skin infections among health care workers in a cancer center. American Journal of Infection Control 39:2, 112-117
CrossRef115
P. Kujath, H. Shekarriz. (2011) Management von Weichgewebeinfektionen im Extremitäten- und Stammbereich. Der Unfallchirurg 114:3, 217-226
CrossRef116
K. J. COMO-SABETTI, K. H. HARRIMAN, S. K. FRIDKIN, S. L. JAWAHIR, R. LYNFIELD. (2011) Risk factors for community-associated Staphylococcus aureus infections: results from parallel studies including methicillin-resistant and methicillin-sensitive S. aureus compared to uninfected controls. Epidemiology and Infection 139:03, 419-429
CrossRef117
Whitney P. Bowe, James J. Leyden. 2011. Clinical implications of antibiotic resistance: risk of systemic infection from Staphylococcus and Streptococcus. , 125-133.
CrossRef118
Nai-Chen Cheng, Jann-Tay Wang, Shan-Chwen Chang, Hao-Chih Tai, Yueh-Bih Tang. (2011) Necrotizing Fasciitis Caused by Staphylococcus aureus. Annals of Plastic Surgery1
CrossRef119
David C. Kaslow, John W. Shiver. (2011) Clostridium difficile and Methicillin-Resistant Staphylococcus aureus: Emerging Concepts in Vaccine Development. Annual Review of Medicine 62:1, 201-215
CrossRef120
C. Liu, A. Bayer, S. E. Cosgrove, R. S. Daum, S. K. Fridkin, R. J. Gorwitz, S. L. Kaplan, A. W. Karchmer, D. P. Levine, B. E. Murray, M. J. Rybak, D. A. Talan, H. F. Chambers. (2011) Clinical Practice Guidelines by the Infectious Diseases Society of America for the Treatment of Methicillin-Resistant Staphylococcus aureus Infections in Adults and Children. Clinical Infectious Diseases 52:3, e18-e55
CrossRef121
David P Nicolau. (2011) Current challenges in the management of the infected patient. Current Opinion in Infectious Diseases 24:Suppl 1, S1-S10
CrossRef122
Marin H. Kollef, Marya D. Zilberberg, Andrew F. Shorr, Lien Vo, Jeffrey Schein, Scott T. Micek, Myoung Kim. (2011) Epidemiology, microbiology and outcomes of healthcare-associated and community-acquired bacteremia: A multicenter cohort study. Journal of Infection 62:2, 130-135
CrossRef123
P Del Giudice, M Bes, T Hubiche, L Roudière, V Blanc, G Lina, F Vandenesch, J Etienne. (2011) Clinical manifestations and outcome of skin infections caused by the community-acquired methicillin-resistant Staphylococcus aureus clone ST80-IV. Journal of the European Academy of Dermatology and Venereology 25:2, 164-169
CrossRef124
T. Conceição, M. Aires-de-Sousa, N. Pona, M. J. Brito, C. Barradas, R. Coelho, T. Sardinha, L. Sancho, G. Sousa, M. Céu Machado, H. Lencastre. (2011) High prevalence of ST121 in community-associated methicillin-susceptible Staphylococcus aureus lineages responsible for skin and soft tissue infections in Portuguese children. European Journal of Clinical Microbiology & Infectious Diseases 30:2, 293-297
CrossRef125
C. Liu, A. Bayer, S. E. Cosgrove, R. S. Daum, S. K. Fridkin, R. J. Gorwitz, S. L. Kaplan, A. W. Karchmer, D. P. Levine, B. E. Murray, M. J. Rybak, D. A. Talan, H. F. Chambers. (2011) Clinical Practice Guidelines by the Infectious Diseases Society of America for the Treatment of Methicillin-Resistant Staphylococcus aureus Infections in Adults and Children: Executive Summary. Clinical Infectious Diseases 52:3, 285-292
CrossRef126
Scott D Kobayashi, Frank R DeLeo. (2011) A MRSA-terious enemy among us: Boosting MRSA vaccines. Nature Medicine 17:2, 168-169
CrossRef127
Larissa May, Katherine Harter, Kabir Yadav, Ryan Strauss, Jameel Abualenain, Amy Keim, Gillian Schmitz. (2011) Practice patterns and management strategies for purulent skin and soft-tissue infections in an urban academic ED. The American Journal of Emergency Medicine
CrossRef128
Hidenobu Kawabata, Manabu Murakami, Kengo Kisa, Masaji Maezawa. (2011) Incidence of Community-associated Methicillin-resistant Staphylococcus aureus Infections in a Regional Hospital. Journal of Rural Medicine 6:1, 22-25
CrossRef129
Rasmus V Rasmussen, Vance G Fowler Jr, Robert Skov, Niels E Bruun. (2011) Future challenges and treatment of Staphylococcus aureus bacteremia with emphasis on MRSA. Future Microbiology 6:1, 43-56
CrossRef130
Thomas Spentzas, Ravi Kudumula, Carlos Acuna, Ajay J. Talati, Kimberly C. Ingram, Fabio Savorgnan, Elizabeth A. Meals, B. Keith English. (2011) Role of bacterial components in macrophage activation by the LAC and MW2 strains of community-associated, methicillin-resistant Staphylococcus aureus. Cellular Immunology 269:1, 46-53
CrossRef131
Catalina Matiz, Wynnis L. Tom, Lawrence F. Eichenfield, Alice Pong, Sheila Fallon Friedlander. (2011) Children with Atopic Dermatitis Appear Less Likely to Be Infected with Community Acquired Methicillin-Resistant Staphylococcus aureus: The San Diego Experience. Pediatric Dermatology 28:1, 6-11
CrossRef132
Pascal Del Giudice, Michèle Bes, Thomas Hubiche, Véronique Blanc, Laurent Roudière, Gérard Lina, François Vandenesch, Jérôme Etienne. (2011) Panton-Valentine Leukocidin-Positive <i>Staphylococcus aureus</i> Strains Are Associated with Follicular Skin Infections. Dermatology 222:2, 167-170
CrossRef133
Rakesh D. Mistry, Halden F. Scott, Theoklis E. Zaoutis, Elizabeth R. Alpern. (2011) Emergency Department Treatment Failures for Skin Infections in the Era of Community-Acquired Methicillin-Resistant Staphylococcus aureus. Pediatric Emergency Care 27:1, 21-26
CrossRef134
J. -M. Forel, S. Valera, M. Castanier. (2011) Infections communautaires graves — Cellulites, dermohypodermites aiguës bactériennes et fasciites nécrosantes. Réanimation 20:S2, 576-582
CrossRef135
David P. Calfee. (2011) The Epidemiology, Treatment, and Prevention of Transmission of Methicillin-Resistant Staphylococcus aureus. Journal of Infusion Nursing 34:6, 359-364
CrossRef136
Praveen Duggal, Iman Naseri, Steven E. Sobol. (2011) The increased risk of community-acquired methicillin-resistant Staphylococcus aureus neck abscesses in young children. The Laryngoscope 121:1, 51-55
CrossRef137
K. Chua, F. Laurent, G. Coombs, M. L. Grayson, B. P. Howden. (2011) Not Community-Associated Methicillin-Resistant Staphylococcus aureus (CA-MRSA)! A Clinician's Guide to Community MRSA - Its Evolving Antimicrobial Resistance and Implications for Therapy. Clinical Infectious Diseases 52:1, 99-114
CrossRef138
Barbara E. Barnes, Deborah A. Sampson. (2011) A literature review on community-acquired methicillin-resistant Staphylococcus aureus in the United States: Clinical information for primary care nurse practitioners. Journal of the American Academy of Nurse Practitioners 23:1, 23-32
CrossRef139
Henry S. Fraimow, Constantine Tsigrelis. (2011) Antimicrobial Resistance in the Intensive Care Unit: Mechanisms, Epidemiology, and Management of Specific Resistant Pathogens. Critical Care Clinics 27:1, 163-205
CrossRef140
Marta Ulldemolins, Xavier Nuvials, Mercedes Palomar, Joan R. Masclans, Jordi Rello. (2011) Appropriateness is Critical. Critical Care Clinics 27:1, 35-51
CrossRef141
Jae-Hoon Song. (2011) Antimicrobial Resistance in Gram-positive Cocci: Past 50 Years, Present and Future. Infection and Chemotherapy 43:6, 443
CrossRef142
Lukas Kreienbuehl, Emmanuel Charbonney, Philippe Eggimann. (2011) Community-acquired necrotizing pneumonia due to methicillin-sensitive Staphylococcus aureus secreting Panton-Valentine leukocidin: a review of case reports. Annals of Intensive Care 1:1, 52
CrossRef143
Sonny Dhanani, Peter N. Cox. 2011. Infectious Syndromes in the Pediatric Intensive Care Unit. , 1336-1348.
CrossRef144
Tara Cassidy-Smith, Rakesh D. Mistry, Christopher J. Russo, Kathryn McCans, Naomi Brown, Lisa M. Capano-Wehrle, Lisa A. Drago, Patty A. Vitale, Brigitte M. Baumann. (2010) Topical anesthetic cream is associated with spontaneous cutaneous abscess drainage in children
. The American Journal of Emergency Medicine
CrossRef145
Steven L Barriere. (2010) ATLAS trials: efficacy and safety of telavancin compared with vancomycin for the treatment of skin infections. Future Microbiology 5:12, 1765-1773
CrossRef146
David J. Farrell, Mariana Castanheira, Helio S. Sader, Ronald N. Jones. (2010) The in vitro evaluation of solithromycin (CEM-101) against pathogens isolated in the United States and Europe (2009). Journal of Infection 61:6, 476-483
CrossRef147
John S. Cho, Caiyun Xuan, Lloyd S. Miller. (2010) Lucky Number Seven: RNase 7 Can Prevent Staphylococcus aureus Skin Colonization. Journal of Investigative Dermatology 130:12, 2703-2706
CrossRef148
Jann-Tay Wang, Jiun-Ling Wang, Chi-Tai Fang, Wei-Chu Chie, Mei-Shu Lai, Tsai-Ling Lauderdale, Chia-Min Weng, Shan-Chwen Chang. (2010) Risk factors for mortality of nosocomial methicillin-resistant Staphylococcus aureus (MRSA) bloodstream infection: With investigation of the potential role of community-associated MRSA strains. Journal of Infection 61:6, 449-457
CrossRef149
Walter P Unger. 2010. Preoperative Preparation and Instructions. , 198-226.
CrossRef150
Marie Antoinette Frick, Fernando A. Moraga-Llop, Rosa Bartolomé, Nieves Larrosa, Magda Campins, Yuani Roman, Ana Vindel, Concepció Figueras. (2010) Infecciones por Staphylococcus aureus resistente a meticilina adquirido en la comunidad en niños. Enfermedades Infecciosas y Microbiología Clínica 28:10, 675-679
CrossRef151
Mei H. Chang, Troy D. Kish, Horatio B. Fung. (2010) Telavancin: A lipoglycopeptide antimicrobial for the treatment of complicated skin and skin structure infections caused by gram-positive bacteria in adults. Clinical Therapeutics 32:13, 2160-2185
CrossRef152
G. R. Corey, M. H. Wilcox, G. H. Talbot, D. Thye, D. Friedland, T. Baculik, , P. Mehra, M. Alpert, I. Baird, S. Klein, J. Litow, P. Marsh, R. Penn, J. Augustinsk, D. Young, C. Bunce, D. Green, R. Eyzaguirre, G. Ambasch, D. J. Curcio, G. Lopardo, A. R. Minguez, M. E. Oliva, O. F. Teglia, M. Campos, P. Gaete, G. Acuna, L. Jansen, A. Jauregui, C. Perez, C. Seas, J. Gutierrez, M. Mayorga, N. A. Bubnova, S. V. Goryunov, K. M. Krylov, E. A. Macheret, A. A. Novozhilov, K. P. Zhidkov, R. S. Kozlov, I. P. Florescu, R. Orasan, V. Trifu, H.-M. Ockenfels, B. Hermes, N. Brockmeyer, E. Dippel, P. Kujath, L. Kowalzick, J. Ulrich, I. Krasnodebski, R. Jaworski, M. Zaniewski, G. Wallner, M. Kapinska-Mrowiecka, A. Dziki, M. Motyka, V. M. Borschivsky, I. D. Gerych, S. M. Lukashov, O. V. Pyptyuk. (2010) CANVAS 1: the first Phase III, randomized, double-blind study evaluating ceftaroline fosamil for the treatment of patients with complicated skin and skin structure infections. Journal of Antimicrobial Chemotherapy 65:Supplement 4, iv41-iv51
CrossRef153
Marya D. Zilberberg, Andrew F. Shorr, Scott T. Micek, Joyce Chen, Andrew M. Ramsey, Alex P. Hoban, Victor Pham, Joshua A. Doherty, Samir H. Mody, Marin H. Kollef. (2010) Hospitalizations with healthcare-associated complicated skin and skin structure infections: Impact of inappropriate empiric therapy on outcomes. Journal of Hospital Medicine 5:9, 535-540
CrossRef154
Heather D. Rogers, Edward B. Desciak, Rebecca P. Marcus, Shuang Wang, Julian MacKay-Wiggan, Yehuda D. Eliezri. (2010) Prospective study of wound infections in Mohs micrographic surgery using clean surgical technique in the absence of prophylactic antibiotics. Journal of the American Academy of Dermatology 63:5, 842-851
CrossRef155
M. S. Dryden. (2010) Complicated skin and soft tissue infection. Journal of Antimicrobial Chemotherapy 65:Supplement 3, iii35-iii44
CrossRef156
G. L. Drusano. (2010) Pharmacodynamics of ceftaroline fosamil for complicated skin and skin structure infection: rationale for improved anti-methicillin-resistant Staphylococcus aureus activity. Journal of Antimicrobial Chemotherapy 65:Supplement 4, iv33-iv39
CrossRef157
Christopher R. Frei, Monica L. Miller, James S. Lewis, Kenneth A. Lawson, Rajesh Peddaiahgari, Robert L. Talbert. (2010) Retrospective cohort study of hospitalized adults treated with vancomycin or clindamycin for methicillin-resistant Staphylococcus aureus skin infections. Clinical Therapeutics 32:12, 2024-2029
CrossRef158
G.L. French. (2010) The continuing crisis in antibiotic resistance. International Journal of Antimicrobial Agents 36, S3-S7
CrossRef159
M. H. Wilcox, G. R. Corey, G. H. Talbot, D. Thye, D. Friedland, T. Baculik, , P. Manos, P. Lee, L. Bush, J. DeSanto, L. Jauregui-Peredo, T. Sheftel, J. Pullman, C. Schrock, H. Standiford, R. Mason, J. Guetzkow, C. Lucasti, J. Surber, S. Lee, V. Samonte, C. G. Rodriguez, J. D. Altclas, C. E. Bergallo, M. A. Mastruzzo, G. I. Morera, S. E. Prieto, C. G. Remolif, A. Timmerman, A. Freire, M. Calvo, C. Chain, A. Llancaqueo, G. Amaya, E. Rodriguez, I. S. Osipov, A. V. Konychev, S. A. Shlyapnikov, A. M. Shulutko, J. Zuckerman, D. Bachter, P. Kohl, M. Schilling, J. Kulig, A. Hartwich, P. Szyber, S. Rudzki, K. Kolomecki, M. Drazkiewicz, M. Gutowska-Jablonska, W. Majewski, F. Trautinger, R. Schandalik, A. Pavars, V. Lovcinoskis, J. Gardovskis, I. Hartmane, E. Zarembo, B. G. Bezrodny, O. B. Datsenko, O. V. Stasyshyn, V. V. Ganzhyi. (2010) CANVAS 2: the second Phase III, randomized, double-blind study evaluating ceftaroline fosamil for the treatment of patients with complicated skin and skin structure infections. Journal of Antimicrobial Chemotherapy 65:Supplement 4, iv53-iv65
CrossRef160
Russell R. Kempker, Monica M. Farley, Janine L. Ladson, Sarah Satola, Susan M. Ray. (2010) Association of methicillin-resistant Staphylococcus aureus (MRSA) USA300 genotype with mortality in MRSA Bacteremia. Journal of Infection 61:5, 372-381
CrossRef161
Adam B. Sivitz, Samuel H.F. Lam, Daniela Ramirez-Schrempp, Jonathan H. Valente, Arun D. Nagdev. (2010) Effect of Bedside Ultrasound on Management of Pediatric Soft-Tissue Infection. The Journal of Emergency Medicine 39:5, 637-643
CrossRef162
Ying-Chi Lin, Marnie L Peterson. (2010) New insights into the prevention of staphylococcal infections and toxic shock syndrome. Expert Review of Clinical Pharmacology 3:6, 753-767
CrossRef163
Michael Otto. (2010) Basis of Virulence in Community-Associated Methicillin-Resistant Staphylococcus aureus *. Annual Review of Microbiology 64:1, 143-162
CrossRef164
Masaaki Higashiyama, Teruyo Ito, Xiao Han, Kenichiro Ono, Kenzo Minamimura, Fumihiro Sakakibara, Akemi Tanno, Junichiro Nishiyama, Junichi Hatada, Keiichi Hiramatsu, Akihiko Kawana. (2010) Epidural abscess caused by community-associated methicillin-resistant Staphylococcus aureus strain USA300 in Japan. Journal of Infection and Chemotherapy 16:5, 345-349
CrossRef165
Michael R Jacobs. (2010) Retapamulin: focus on its use in the treatment of uncomplicated superficial skin infections and impetigo. Expert Review of Dermatology 5:5, 505-517
CrossRef166
Shizuka Yabe, Tomomi Takano, Wataru Higuchi, Shigenao Mimura, Yoshihiro Kurosawa, Tatsuo Yamamoto. (2010) Spread of the community-acquired methicillin-resistant Staphylococcus aureus USA300 clone among family members in Japan. Journal of Infection and Chemotherapy 16:5, 372-374
CrossRef167
Andrea Ries Thurman, Yadira Anca, Cassandra A. White, David E. Soper. (2010) Post-cesarean delivery infectious morbidity: Focus on preoperative antibiotics and methicillin-resistant Staphylococcus aureus. American Journal of Infection Control 38:8, 612-616
CrossRef168
Anneliese M. Schleyer, Kenneth M. Jarman, Jeannie D. Chan, Timothy H. Dellit. (2010) Role of nasal methicillin-resistant Staphylococcus aureus screening in the management of skin and soft tissue infections. American Journal of Infection Control 38:8, 657-659
CrossRef169
Natalie L. McCarthy, Patrick S. Sullivan, Robert Gaynes, David Rimland. (2010) Health care-associated and community-associated methicillin-resistant Staphylococcus aureus infections: A comparison of definitions. American Journal of Infection Control 38:8, 600-606
CrossRef170
Brian C. Pien, Punidha Sundaram, Natalia Raoof, Sylvia F. Costa, Stanley Mirrett, Christopher W. Woods, L. Barth Reller, Melvin P. Weinstein. (2010) The Clinical and Prognostic Importance of Positive Blood Cultures in Adults. The American Journal of Medicine 123:9, 819-828
CrossRef171
Robin A. Pollini, Manuel Gallardo, Samreen Hasan, Joshua Minuto, Remedios Lozada, Alicia Vera, María Luisa Zúñiga, Steffanie A. Strathdee. (2010) High prevalence of abscesses and self-treatment among injection drug users in Tijuana, Mexico. International Journal of Infectious Diseases 14, e117-e122
CrossRef172
Jeffry L. Kashuk, Ernest E. Moore, Connie S. Price, Christopher Zaw-Mon, Theresa Nino, James Haenel, Walter L. Biffl, C. Cothren Burlew, Jeffrey L. Johnson. (2010) Patterns of Early and Late Ventilator-Associated Pneumonia Due to Methicillin-Resistant Staphylococcus aureus in a Trauma Population. The Journal of Trauma: Injury, Infection, and Critical Care 69:3, 519-522
CrossRef173
Shey-Ying Chen, Jann-Tay Wang, Tony Hsiu-Hsi Chen, Mei-Shu Lai, Wei-Chu Chie, Kuo-Liong Chien, Po-Ren Hsueh, Jiun-Ling Wang, Shan-Chwen Chang. (2010) Impact of Traditional Hospital Strain of Methicillin-Resistant Staphylococcus aureus (MRSA) and Community Strain of MRSA on Mortality in Patients With Community-Onset S aureus Bacteremia. Medicine 89:5, 285-294
CrossRef174
Gonzalo M.L. Bearman, Adriana E. Rosato, Susan Assanasen, Elizabeth A. Kleiner, Kara Elam, Cheryl Haner, Richard P. Wenzel. (2010) Nasal carriage of inducible dormant and community-associated methicillin-resistant Staphylococcus aureus in an ambulatory population of predominantly university students. International Journal of Infectious Diseases 14, e18-e24
CrossRef175
Evan M. Feldman, Dimitrios P. Kontoyiannis, Safa E. Sharabi, Edward Lee, Yoav Kaufman, Lior Heller. (2010) Breast Implant Infections: Is Cefazolin Enough?. Plastic and Reconstructive Surgery 126:3, 779-785
CrossRef176
Karen K. Kinney. (2010) Treatment of Infections Caused By Antimicrobial-Resistant Gram-Positive Bacteria. The American Journal of the Medical Sciences 340:3, 209-217
CrossRef177
Daniel Curcio. (2010) Resistant pathogen-associated skin and skin-structure infections: antibiotic options. Expert Review of Anti-infective Therapy 8:9, 1019-1036
CrossRef178
Kevin P. Blaine, Marion J. Tuohy, Deborah Wilson, Gary W. Procop, Daniel J. Tisch, Nabin K. Shrestha, Geraldine S. Hall. (2010) Progression to bacteremia in critical care patients colonized with methicillin-resistant Staphylococcus aureus expressing Panton–Valentine leukocidin. Diagnostic Microbiology and Infectious Disease 68:1, 28-33
CrossRef179
Behin Barahimi, Ann P. Murchison, Jurij R. Bilyk. (2010) Forget Me Not. Survey of Ophthalmology 55:5, 467-480
CrossRef180
Alison J. Carey, Sarah S. Long. (2010) Staphylococcus aureus: A Continuously Evolving and Formidable Pathogen in the Neonatal Intensive Care Unit. Clinics in Perinatology 37:3, 535-546
CrossRef181
Robert C. Moellering. (2010) Why Has Methicillin-Resistant Staphylococcus aureus Become Such a Successful Pathogen in Adults?. Infectious Diseases in Clinical Practice 18:5, 286-291
CrossRef182
Joseph D. Forrester, Christopher P. Holstege. (2010) A Mystery Infection. Wilderness & Environmental Medicine 21:3, 262-264
CrossRef183
D. M. Sievert, M. L. Wilson, M. J. Wilkins, B. W. Gillespie, M. L. Boulton. (2010) Public Health Surveillance for Methicillin-Resistant Staphylococcus aureus: Comparison of Methods for Classifying Health Care- and Community-Associated Infections. American Journal of Public Health 100:9, 1777-1783
CrossRef184
D. Mertz, R. Frei, N. Periat, C. Scheidegger, M. Battegay, W. Seiler, A. F. Widmer. (2010) Eradication of an epidemic methicillin-resistant Staphylococcus aureus (MRSA) from a geriatric university hospital: evidence from a 10-year follow-up. European Journal of Clinical Microbiology & Infectious Diseases 29:8, 987-993
CrossRef185
M. C. Wehrhahn, J. O. Robinson, J. C. Pearson, F. G. O’Brien, H. L. Tan, G. W. Coombs, E. M. Pascoe, R. Lee, P. Salvaris, R. Salvaris, D. New, R. J. Murray. (2010) Clinical and laboratory features of invasive community-onset methicillin-resistant Staphylococcus aureus infection: a prospective case–control study. European Journal of Clinical Microbiology & Infectious Diseases 29:8, 1025-1033
CrossRef186
Bruce C. Friedman, Luke Mendez-Vigo, Joan Wilson, Sara Yankelev. (2010) A Retrospective Review of Clinical Experience with Daptomycin for a Variety of Wound Types in a Burn and Wound Care Facility. Southern Medical Journal 103:8, 748-752
CrossRef187
J.M. Orendi, N. Coetzee, M.J. Ellington, E. Boakes, B.D. Cookson, K.J. Hardy, P.M. Hawkey, A.M. Kearns. (2010) Community and nosocomial transmission of Panton–Valentine leucocidin-positive community-associated meticillin-resistant Staphylococcus aureus: implications for healthcare. Journal of Hospital Infection 75:4, 258-264
CrossRef188
Dick C. Kuo, Rose M. Chasm, Michael D. Witting. (2010) Emergency Physician Ability to Predict Methicillin-Resistant Staphylococcus aureus Skin and Soft Tissue Infections. The Journal of Emergency Medicine 39:1, 17-20
CrossRef189
Steven M. Zinder, Rodney S. W. Basler, Jack Foley, Chris Scarlata, David B. Vasily. (2010) National Athletic Trainers' Association Position Statement: Skin Diseases. Journal of Athletic Training 45:4, 411-428
CrossRef190
Eric M. Matheson, Arch G. Mainous, William J. Hueston, Vanessa A. Diaz, Charles J. Everett. (2010) Vitamin D and methicillin-resistant Staphylococcus aureus nasal carriage. Scandinavian Journal of Infectious Diseases 42:6-7, 455-460
CrossRef191
Louis D. Saravolatz, Joan Pawlak, Leonard B. Johnson. (2010) In vitro activity of oritavancin against community-associated meticillin-resistant Staphylococcus aureus (CA-MRSA), vancomycin-intermediate S. aureus (VISA), vancomycin-resistant S. aureus (VRSA) and daptomycin-non-susceptible S. aureus (DNSSA). International Journal of Antimicrobial Agents 36:1, 69-72
CrossRef192
Arthur Jeng, Manie Beheshti, John Li, Ramesh Nathan. (2010) The Role of β-Hemolytic Streptococci in Causing Diffuse, Nonculturable Cellulitis. Medicine 89:4, 217-226
CrossRef193
Susan M. Lareau, Leslie Meyn, Richard H. Beigi. (2010) Methicillin-Resistant Staphylococcus aureus as the Most Common Cause of Perineal Abscesses. Infectious Diseases in Clinical Practice 18:4, 258-260
CrossRef194
Natasha Atanaskova, Kenneth J. Tomecki. (2010) Innovative Management of Recurrent Furunculosis. Dermatologic Clinics 28:3, 479-487
CrossRef195
Nancy F Crum-Cianflone, Greg Grandits, Sara Echols, Anuradha Ganesan, Michael Landrum, Amy Weintrob, Robert Barthel, Brian Agan. (2010) Trends and Causes of Hospitalizations Among HIV-Infected Persons During the Late HAART Era: What Is the Impact of CD4 Counts and HAART Use?. JAIDS Journal of Acquired Immune Deficiency Syndromes 54:3, 248-257
CrossRef196
Marcia Redwood, Robert McCabe. (2010) Four Cases of Community-Associated Methicillin-Resistant Staphylococcus aureus Pericarditis. Infectious Diseases in Clinical Practice 18:4, 251-252
CrossRef197
Benjamin A. Busch, Matthew T. Ahern, Marcus Topinka, James J. Jenkins, Michael A. Weiser. (2010) Eschar with Cellulitis as a Clinical Predictor in Community-Acquired Methicillin-Resistant Staphylococcus Aureus (MRSA) Skin Abscess. The Journal of Emergency Medicine 38:5, 563-566
CrossRef198
Erin A. Chuck, Bradley W. Frazee, Larry Lambert, Robert McCabe. (2010) The Benefit of Empiric Treatment for Methicillin-Resistant Staphylococcus Aureus. The Journal of Emergency Medicine 38:5, 567-571
CrossRef199
S. Perbet, A. Soummer, C. Vinsonneau, A. Vandebrouck, T. Rackelboom, J. Etienne, A. Cariou, J.-D. Chiche, J.-P. Mira, J. Charpentier. (2010) Multifocal community-acquired necrotizing fasciitis caused by a Panton-Valentine leukocidin-producing methicillin-sensitive Staphylococcus aureus. Infection 38:3, 223-225
CrossRef200
David J. Farrell, Marion Robbins, William Rhys-Williams, William G. Love. (2010) In vitro activity of XF-73, a novel antibacterial agent, against antibiotic-sensitive and -resistant Gram-positive and Gram-negative bacterial species. International Journal of Antimicrobial Agents 35:6, 531-536
CrossRef201
P. Gilligan, M. Quirke, S. Winder, H. Humphreys. (2010) Impact of admission screening for meticillin-resistant Staphylococcus aureus on the length of stay in an emergency department. Journal of Hospital Infection 75:2, 99-102
CrossRef202
F. J. Cooke, N. M. Brown. (2010) Community-associated methicillin-resistant Staphylococcus aureus infections. British Medical Bulletin 94:1, 215-227
CrossRef203
Christine A Odell. (2010) Community-associated methicillin-resistant Staphylococcus aureus (CA-MRSA) skin infections. Current Opinion in Pediatrics 22:3, 273-277
CrossRef204
John S. Cho, Eric M. Pietras, Nairy C. Garcia, Romela Irene Ramos, David M. Farzam, Holly R. Monroe, Julie E. Magorien, Andrew Blauvelt, Jay K. Kolls, Ambrose L. Cheung, Genhong Cheng, Robert L. Modlin, Lloyd S. Miller. (2010) IL-17 is essential for host defense against cutaneous Staphylococcus aureus infection in mice. Journal of Clinical Investigation 120:5, 1762-1773
CrossRef205
V. A. Luna, T. J. Hall, D. S. King, A. C. Cannons. (2010) Susceptibility of 169 USA300 methicillin-resistant Staphylococcus aureus isolates to two copper-based biocides, CuAL42 and CuWB50. Journal of Antimicrobial Chemotherapy 65:5, 939-941
CrossRef206
E. S. Yang, J. Tan, S. Eells, G. Rieg, G. Tagudar, L. G. Miller. (2010) Body site colonization in patients with community-associated methicillin-resistant Staphylococcus aureus and other types of S. aureus skin infections. Clinical Microbiology and Infection 16:5, 425-431
CrossRef207
Frank R DeLeo, Michael Otto, Barry N Kreiswirth, Henry F Chambers. (2010) Community-associated meticillin-resistant Staphylococcus aureus. The Lancet 375:9725, 1557-1568
CrossRef208
Rakesh D. Mistry, Halden F. Scott, Elizabeth R. Alpern, Theoklis E. Zaoutis. (2010) Prevalence of Proteus mirabilis in Skin Abscesses of the Axilla. The Journal of Pediatrics 156:5, 850-851
CrossRef209
M. GIULIANI, B. LONGO, A. LATINI, G. PRIGNANO, M. MONACO, A. DE SANTIS, G. IMPARA, G. PALAMARA, A. PANTOSTI. (2010) No evidence of colonization with community-acquired methicillin-resistant Staphylococcus aureus in HIV-1-infected men who have sex with men. Epidemiology and Infection 138:05, 738
CrossRef210
Brian C. Diener. (2010) Avoidance of Dominant Hand Amputation in a Patient with Uncontrolled Diabetes. Advances in Skin & Wound Care 23:5, 219-222
CrossRef211
E. LLOYD-SMITH, M. W. HULL, M. W. TYNDALL, R. ZHANG, E. WOOD, J. S. G. MONTANER, T. KERR, M. G. ROMNEY. (2010) Community-associated methicillin-resistant Staphylococcus aureus is prevalent in wounds of community-based injection drug users. Epidemiology and Infection 138:05, 713
CrossRef212
Pablo Rojo, Marta Barrios, Alba Palacios, Carmen Gomez, Fernando Chaves. (2010) Community-associated Staphylococcus aureus infections in children. Expert Review of Anti-infective Therapy 8:5, 541-554
CrossRef213
Alex G. Ortega-Loayza, Stephanie A. Diamantis, Peter Gilligan, Dean S. Morrell. (2010) Characterization of Staphylococcus aureus cutaneous infections in a pediatric dermatology tertiary health care outpatient facility. Journal of the American Academy of Dermatology 62:5, 804-811
CrossRef214
A. J. KALLEN, C. REED, M. PATTON, K. E. ARNOLD, L. FINELLI, J. HAGEMAN. (2010) Staphylococcus aureus community-onset pneumonia in patients admitted to children's hospitals during autumn and winter of 2006–2007. Epidemiology and Infection 138:05, 666
CrossRef215
Carlos M Luna, Iris D Boyeras Navarro. (2010) Management of methicillin-resistant Staphylococcus aureus pneumonia. Current Opinion in Infectious Diseases 23:2, 178-184
CrossRef216
Lena M. Napolitano. (2010) Perspectives in Surgical Infections: What Does the Future Hold?. Surgical Infections 11:2, 111-123
CrossRef217
Jonathan A Otter, Gary L French. (2010) Molecular epidemiology of community-associated meticillin-resistant Staphylococcus aureus in Europe. The Lancet Infectious Diseases 10:4, 227-239
CrossRef218
P. Del Giudice, P. Hubiche. (2010) Community-associated methicillin-resistant Staphylococcus aureus and impetigo. British Journal of Dermatology 162:4, 905-905
CrossRef219
S. CHIRA, L. G. MILLER. (2010) Staphylococcus aureus is the most common identified cause of cellulitis: a systematic review. Epidemiology and Infection 138:03, 313
CrossRef220
Randall J. Olsen, Scott D. Kobayashi, Ara A. Ayeras, Madiha Ashraf, Shawna F. Graves, Willie Ragasa, Tammy Humbird, Jamieson L. Greaver, Constance Cantu, Jody L. Swain, Leslie Jenkins, Terry Blasdel, Philip T. Cagle, Donald J. Gardner, Frank R. DeLeo, James M. Musser. (2010) Lack of a Major Role of Staphylococcus aureus Panton-Valentine Leukocidin in Lower Respiratory Tract Infection in Nonhuman Primates. The American Journal of Pathology 176:3, 1346-1354
CrossRef221
X Bertrand. (2010) Methicillin-resistant Staphylococcus aureus : an ever emerging threat. Therapy 7:2, 169-178
CrossRef222
Gary E. Stein, Elizabeth M. Wells. (2010) The importance of tissue penetration in achieving successful antimicrobial treatment of nosocomial pneumonia and complicated skin and soft-tissue infections caused by methicillin-resistant Staphylococcus aureus : vancomycin and linezolid. Current Medical Research and Opinion 26:3, 571-588
CrossRef223
Rakesh D. Mistry, Keith Weisz, Halden F. Scott, Elizabeth R. Alpern. (2010) Emergency Management of Pediatric Skin and Soft Tissue Infections in the Community-associated Methicillin-resistant Staphylococcus aureus Era. Academic Emergency Medicine 17:2, 187-193
CrossRef224
Mark Bounthavong, Donald I. Hsu. (2010) Efficacy and safety of linezolid in methicillin-resistant Staphylococcus aureus (MRSA) complicated skin and soft tissue infection (cSSTI): a meta-analysis. Current Medical Research and Opinion 26:2, 407-421
CrossRef225
Sanjai Saxena, Charu Gomber. (2010) Surmounting antimicrobial resistance in the Millennium Superbug: Staphylococcus aureus. Central European Journal of Medicine 5:1, 12-29
CrossRef226
Silva Holtfreter, Julia Kolata, Barbara M. Bröker. (2010) Towards the immune proteome of Staphylococcus aureus – The anti-S. aureus antibody response. International Journal of Medical Microbiology 300:2-3, 176-192
CrossRef227
Kamaleldin B. Said, Guoqiang Zhu, Xin Zhao. (2010) Organ- and Host-Specific Clonal Groups of Staphylococcus aureus from Human Infections and Bovine Mastitis Revealed by the Clumping Factor A Gene. Foodborne Pathogens and Disease 7:2, 111-119
CrossRef228
Chris J. Pasetka, Douglas J. Erfle, Dale R. Cameron, Jacob J. Clement, Evelina Rubinchik. (2010) Novel antimicrobial lipopeptides with long in vivo half-lives. International Journal of Antimicrobial Agents 35:2, 182-185
CrossRef229
Shawna F. Graves, Scott D. Kobayashi, Frank R. DeLeo. (2010) Community-associated methicillin-resistant Staphylococcus aureus immune evasion and virulence. Journal of Molecular Medicine 88:2, 109-114
CrossRef230
F. Dumas, G. Kierzek, J.-L. Pourriat. (2010) Infezioni cutanee. EMC - Urgenze 14:1, 1-10
CrossRef231
Hidenobu Kawabata, Manabu Murakami, Kengo Kisa, Yuya Kimura, Masaji Maezawa. (2010) A Case of Community-Associated Methicillin-Resistant Staphylococcus Aureus Infections in a Community Hospital. Journal of Rural Medicine 5:1, 140-143
CrossRef232
Molly Price. (2010) Community-Acquired Methicillin-Resistant Staphylococcus Aureus. Journal of Wound, Ostomy and Continence Nursing 37:6, 633-638
CrossRef233
M. Daskalaki, P. Rojo, M. Marin-Ferrer, M. Barrios, J. R. Otero, F. Chaves. (2010) PantonâValentine leukocidin-positive Staphylococcus aureus skin and soft tissue infections among children in an emergency department in Madrid, Spain. Clinical Microbiology and Infection 16:1, 74-77
CrossRef234
Liang Beibei, Cai Yun, Chen Mengli, Bai Nan, Yu Xuhong, Wang Rui. (2010) Linezolid versus vancomycin for the treatment of Gram-positive bacterial infections: meta-analysis of randomised controlled trials. International Journal of Antimicrobial Agents 35:1, 3-12
CrossRef235
Sharon Lewin. 2010. Gender Differences in Emerging Infectious Diseases. , 497-515.
CrossRef236
Ashok Srinivasan, Steven Seifried, Liang Zhu, Wally Bitar, Deo K. Srivastava, Jerry L. Shenep, Matthew J. Bankowski, Patricia M. Flynn, Randall T. Hayden. (2009) Short Communication: Methicillin-Resistant Staphylococcus aureus Infections in Children and Young Adults Infected with HIV. AIDS Research and Human Retroviruses 25:12, 1219-1224
CrossRef237
G. Ralph Corey, Martin E. Stryjewski, Wim Weyenberg, Uma Yasothan, Peter Kirkpatrick. (2009) Telavancin. Nature Reviews Drug Discovery 8:12, 929-930
CrossRef238
W. Witte. (2009) Community-acquired methicillin-resistant Staphylococcus aureus : what do we need to know?. Clinical Microbiology and Infection 15, 17-25
CrossRef239
G Lorette, Ph Beaulieu, FA Allaert, A Mahmoudi, V Jarlier. (2009) Superficial community-acquired skin infections: prevalence of bacteria and antibiotic susceptibility in France. Journal of the European Academy of Dermatology and Venereology 23:12, 1423-1426
CrossRef240
Anthony Pickett, Matt Wilkinson, Margaret Menoch, Jennifer Snell, Robert Yniguez, Blake Bulloch. (2009) Changing Incidence of Methicillin-Resistant Staphylococcus aureus Skin Abscesses in a Pediatric Emergency Department. Pediatric Emergency Care 25:12, 831-834
CrossRef241
Y. Liu, F. Kong, X. Zhang, M. Brown, L. Ma, Y. Yang. (2009) Antimicrobial susceptibility of Staphylococcus aureus isolated from children with impetigo in China from 2003 to 2007 shows community-associated methicillin-resistant Staphylococcus aureus to be uncommon and heterogeneous. British Journal of Dermatology 161:6, 1347-1350
CrossRef242
Alfredo Sabbaj, Brett Jensen, Mary Ann Browning, O. John Ma, Craig D. Newgard. (2009) Soft Tissue Infections and Emergency Department Disposition: Predicting the Need for Inpatient Admission. Academic Emergency Medicine 16:12, 1290-1297
CrossRef243
Stephanie A. Fritz, Emma K. Epplin, Jane Garbutt, Gregory A. Storch. (2009) Skin infection in children colonized with community-associated methicillin-resistant Staphylococcus aureus. Journal of Infection 59:6, 394-401
CrossRef244
Dennis A. K. Rice, Luke Mendez-Vigo. (2009) Daptomycin in bone and joint infections: a review of the literature. Archives of Orthopaedic and Trauma Surgery 129:11, 1495-1504
CrossRef245
Andy O. Miller, Michael Henry. (2009) Update in Diagnosis and Treatment of Diabetic Foot Infections. Physical Medicine and Rehabilitation Clinics of North America 20:4, 611-625
CrossRef246
Maria Cícera Silva-Carvalho, Raquel Regina Bonelli, Raquel Rodrigues Souza, Simone Moreira, Lia Cristina Galvão dos Santos, Magda de Souza Conceição, Silvio José de Mello Junior, Jupira Miron Carballido, Priscila Nobrega Rito, Verônica Viana Vieira, Lenise Arneiro Teixeira, Agnes Marie Sá Figueiredo. (2009) Emergence of multiresistant variants of the community-acquired methicillin-resistant Staphylococcus aureus lineage ST1-SCCmecIV in 2 hospitals in Rio de Janeiro, Brazil. Diagnostic Microbiology and Infectious Disease 65:3, 300-305
CrossRef247
Kerry B. Broderick, Megan L. Ranney, Federico E. Vaca, Gail D’Onofrio, Richard E. Rothman, Karin V. Rhodes, Bruce Becker, Jason S. Haukoos. (2009) Study Designs and Evaluation Models for Emergency Department Public Health Research. Academic Emergency Medicine 16:11, 1124-1131
CrossRef248
Manuel Guzmán-Blanco, Carlos Mejía, Raul Isturiz, Carlos Alvarez, Luis Bavestrello, Eduardo Gotuzzo, Jaime Labarca, Carlos M. Luna, Eduardo Rodríguez-Noriega, Mauro J.C. Salles, Jeannete Zurita, Carlos Seas. (2009) Epidemiology of meticillin-resistant Staphylococcus aureus (MRSA) in Latin America. International Journal of Antimicrobial Agents 34:4, 304-308
CrossRef249
, O. Gallon, C. Guillet-Caruba, B. Lamy, F. Laurent, F. Doucet-Populaire, J.-W. Decousser. (2009) In vitro activity of daptomycin against Staphylococci isolated from bacteremia and community-onset skin and soft tissue infections in France: data from two nationwide studies. European Journal of Clinical Microbiology & Infectious Diseases 28:10, 1209-1215
CrossRef250
Helio S. Sader, Ronald N. Jones. (2009) Antimicrobial susceptibility of Gram-positive bacteria isolated from US medical centers: results of the Daptomycin Surveillance Program (2007–2008). Diagnostic Microbiology and Infectious Disease 65:2, 158-162
CrossRef251
Lisa Hall Zimmerman, James G. Tyburski, Alexander Stoffan, Alfred E. Baylor, Heather S. Dolman, Lance M. Brinks, Harold Obiakor, Robert F. Wilson. (2009) Twelve hundred abscesses operatively drained: An antibiotic conundrum?. Surgery 146:4, 794-800
CrossRef252
Anne Stone, Lynne Quittell, Juyan Zhou, Luis Alba, Meera Bhat, Joan DeCelie-Germana, Sujatha Rajan, Lynn Bonitz, John J. Welter, Allen J. Dozor, Ingrid Gherson, Franklin D. Lowy, Lisa Saiman. (2009) Staphylococcus aureus Nasal Colonization Among Pediatric Cystic Fibrosis Patients and Their Household Contacts. The Pediatric Infectious Disease Journal 28:10, 895-899
CrossRef253
Pamela A Moise, Donald North, Judith N Steenbergen, George Sakoulas. (2009) Susceptibility relationship between vancomycin and daptomycin in Staphylococcus aureus: facts and assumptions. The Lancet Infectious Diseases 9:10, 617-624
CrossRef254
Fernando Salgado Ordóñez, Ascensión Arroyo Nieto, Ana Belén Lozano Serrano, Ana Hidalgo Conde, José Verdugo Carballeda. (2009) Infecciones de piel y partes blandas. Medicina Clínica 133:14, 552-564
CrossRef255
Linda Papa, Nathan Kuppermann, Katherine Lamond, William G. Barsan, Carlos A. Camargo, Joseph P. Ornato, Ian G. Stiell, David A. Talan. (2009) Structure and Function of Emergency Care Research Networks: Strengths, Weaknesses, and Challenges. Academic Emergency Medicine 16:10, 995-1004
CrossRef256
Tom van der Poll, Steven M Opal. (2009) Pathogenesis, treatment, and prevention of pneumococcal pneumonia. The Lancet 374:9700, 1543-1556
CrossRef257
Mamta Sharma, Louis D. Saravolatz. 2009. Severe Skin and Soft Tissue Infections inCritical Care. , 295-321.
CrossRef258
Martin E Stryjewski, G Ralph Corey. (2009) New treatments for methicillin-resistant Staphylococcus aureus. Current Opinion in Critical Care 15:5, 403-412
CrossRef259
Lena M. Napolitano. (2009) Severe Soft Tissue Infections. Infectious Disease Clinics of North America 23:3, 571-591
CrossRef260
Joanna Shepherd, Ian Douglas, Stephen Rimmer, Linda Swanson, Sheila MacNeil. (2009) Development of Three-Dimensional Tissue-Engineered Models of Bacterial Infected Human Skin Wounds. Tissue Engineering Part C: Methods 15:3, 475-484
CrossRef261
F. C. Tenover, R. V. Goering. (2009) Methicillin-resistant Staphylococcus aureus strain USA300: origin and epidemiology. Journal of Antimicrobial Chemotherapy 64:3, 441-446
CrossRef262
Henry F. Chambers, Frank R. DeLeo. (2009) Waves of resistance: Staphylococcus aureus in the antibiotic era. Nature Reviews Microbiology 7:9, 629-641
CrossRef263
J.W.T. Elston, G.D. Barlow. (2009) Community-associated MRSA in the United Kingdom. Journal of Infection 59:3, 149-155
CrossRef264
Ioannis G. Baraboutis, Maria Koukoulaki, Helen Belesiotou, Evaggelia Platsouka, Vassilios Papastamopoulos, Dimitrios Kontothanasis, Katerina Kontogianni-Katsarou, Eleftheria P. Tsagalou, Olga Paniara, Athanasios T. Skoutelis. (2009) Community-Acquired Methicillin-Resistant Staphylococcus aureus as a Cause of Rapidly Progressing Pyelonephritis With Pyonephrosis, Necessitating Emergent Nephrectomy. The American Journal of the Medical Sciences 338:3, 233-235
CrossRef265
Loren G. Miller, Helen Boucher. (2009) Rifampin-containing regimens for community-associated skin infection: a hazard without known benefit. The American Journal of Emergency Medicine 27:7, 893-894
CrossRef266
Dennis L. Stevens. (2009) Treatments for skin and soft-tissue and surgical site infections due to MDR Gram-positive bacteria. Journal of Infection 59, S32-S39
CrossRef267
Frank R. DeLeo, Henry F. Chambers. (2009) Reemergence of antibiotic-resistant Staphylococcus aureus in the genomics era. Journal of Clinical Investigation 119:9, 2464-2474
CrossRef268
James H. Diaz. (2009) Recognition, Management, and Prevention of Hymenopteran Stings and Allergic Reactions in Travelers. Journal of Travel Medicine 16:5, 357-364
CrossRef269
Patricia L Schirmer, Stanley C Deresinski. (2009) Ceftobiprole: a new cephalosporin for the treatment of skin and skin structure infections. Expert Review of Anti-infective Therapy 7:7, 777-791
CrossRef270
R. Segal, M. Dan, G. Eger, E. Lubart, A. Leibovitz. (2009) Staphylococcus aureus colonization in the nasopharynx of nasogastric tube-fed patients in a long-term care facility. European Journal of Clinical Microbiology & Infectious Diseases 28:9, 1147-1149
CrossRef271
S. Monecke, R. Ehricht, P. Slickers, H.-L. Tan, G. Coombs. (2009) The molecular epidemiology and evolution of the Panton-Valentine leukocidin-positive, methicillin-resistant Staphylococcus aureus strain USA300 in Western Australia. Clinical Microbiology and Infection 15:8, 770-776
CrossRef272
Carol L. Moore, Ameet Hingwe, Susan M. Donabedian, Mary B. Perri, Susan L. Davis, Nadia Z. Haque, Katherine Reyes, Dora Vager, Marcus J. Zervos. (2009) Comparative evaluation of epidemiology and outcomes of methicillin-resistant Staphylococcus aureus (MRSA) USA300 infections causing community- and healthcare-associated infections. International Journal of Antimicrobial Agents 34:2, 148-155
CrossRef273
Alicia Rico, José Ramón Paño-Pardo, María Luisa Montes, Jesús Mingorance. (2009) Varón homosexual con virus de la inmunodeficiencia humana con fiebre y lesión cutánea. Enfermedades Infecciosas y Microbiología Clínica 27:7, 419-421
CrossRef274
J.W.T. Elston, J. Meigh, A.M. Kearns, N. Jordan-Owers, A. Newton, R.E. Meigh, G. Barlow. (2009) Community-associated meticillin-resistant Staphylococcus aureus: epidemiology, microbiology and clinical impact in East Yorkshire, UK. Journal of Hospital Infection 72:4, 307-313
CrossRef275
Rakesh D. Mistry, Sandra H. Schwab, James R. Treat. (2009) Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis. Pediatric Emergency Care 25:8, 519-522
CrossRef276
J. A. Otter, N. L. Havill, J. M. Boyce, G. L. French. (2009) Comparison of community-associated meticillin-resistant Staphylococcus aureus from teaching hospitals in London and the USA, 2004–2006: where is USA300 in the UK?. European Journal of Clinical Microbiology & Infectious Diseases 28:7, 835-839
CrossRef277
Serhat Unal. (2009) Treatment options for skin and soft tissue infections: ‘oldies but goldies’. International Journal of Antimicrobial Agents 34, S20-S23
CrossRef278
John Segreti. (2009) Review of question and answer session. International Journal of Antimicrobial Agents 34, S36-S38
CrossRef279
Matteo Bassetti, Elena Nicco, Malgorzata Mikulska. (2009) Why is community-associated MRSA spreading across the world and how will it change clinical practice?. International Journal of Antimicrobial Agents 34, S15-S19
CrossRef280
Nancy Crum-Cianflone, Jhamillia Weekes, Mary Bavaro. (2009) Recurrent Community-Associated Methicillin-Resistant Staphylococcus aureus Infections among HIV-Infected Persons: Incidence and Risk Factors. AIDS Patient Care and STDs 23:7, 499-502
CrossRef281
Kenneth R Lawrence, Monica V Golik, Lisa Davidson. (2009) The Role of Primary Care Prescribers in the Diagnosis and Management of Community-Associated Methicillin-Resistant Staphylococcus aureus Skin and Soft Tissue Infections. American Journal of Therapeutics 16:4, 333-338
CrossRef282
Hemant Chatrath, Amit Arora, Hiren Mehta, Stefan Tchernodrinski. (2009) Lemierre Syndrome Caused by Community-Acquired Methicillin-Resistant Staphylococcus aureus. Infectious Diseases in Clinical Practice 17:4, 288-290
CrossRef283
P. Del Giudice, V. Blanc-Amrane, M. Bes, G. Lina, T. Hubiche, E. Counillon, F. Vandenesch, J. Etienne. (2009) Infection cutanée autochtone due au clone de Staphylococcus aureus méthicilline-résistant USA300 en France. Annales de Dermatologie et de Vénéréologie 136:6-7, 541-542
CrossRef284
D.A. Enoch, J.A. Karas, S.H. Aliyu. (2009) Oral antimicrobial options for the treatment of skin and soft-tissue infections caused by meticillin-resistant Staphylococcus aureus (MRSA) in the UK. International Journal of Antimicrobial Agents 33:6, 497-502
CrossRef285
Slade O Jensen, Bruce R Lyon. (2009) Genetics of antimicrobial resistance in Staphylococcus aureus. Future Microbiology 4:5, 565-582
CrossRef286
Timothy A Tolbert, Helen M Binkley. (2009) Prevention of Community-Associated Methicillin-Resistant Staphylococcus Aureus in the Athletic Environment. Strength and Conditioning Journal 31:3, 85-90
CrossRef287
Alicia I Hidron, Cari E Low, Eric G Honig, Henry M Blumberg. (2009) Emergence of community-acquired meticillin-resistant Staphylococcus aureus strain USA300 as a cause of necrotising community-onset pneumonia. The Lancet Infectious Diseases 9:6, 384-392
CrossRef288
Bradley W. Frazee, Shandi Hansen, Larry Lambert. (2009) Invasive Infection With Hypermucoviscous Klebsiella pneumoniae: Multiple Cases Presenting to a Single Emergency Department in the United States. Annals of Emergency Medicine 53:5, 639-642
CrossRef289
Edward A. Dominguez. (2009) Single-Agent Therapy With Tigecycline in the Treatment of Complicated Skin and Skin Structure and Complicated Intraabdominal Infections. Infectious Diseases in Clinical Practice 17:3, 144-149
CrossRef290
Richard S. Vetter. (2009) The Distribution of Brown Recluse Spiders in the Southeastern Quadrant of the United States in Relation to Loxoscelism Diagnoses. Southern Medical Journal 102:5, 518-522
CrossRef291
Adam L. Hersh, Peggy S. Weintrub, Michael D. Cabana. (2009) Antibiotic Selection for Purulent Skin and Soft-Tissue Infections in Ambulatory Care: A Decision-Analytic Approach. Academic Pediatrics 9:3, 179-184
CrossRef292
S. Burgassi, I. Zanardi, V. Travagli, E. Montomoli, V. Bocci. (2009) How much ozone bactericidal activity is compromised by plasma components?. Journal of Applied Microbiology 106:5, 1715-1721
CrossRef293
GEORGE Y. LIU. (2009) Molecular Pathogenesis of Staphylococcus aureus Infection. Pediatric Research 65:Supplement, 71R-77R
CrossRef294
Kamal M.F. Itani, Kasem S. Akhras, Robert Stellhorn, Alvaro Quintana, David Budd, Sanjay Merchant. (2009) Outcomes Associated with Initial versus Later Vancomycin Use in Patients with Complicated Skin and Skin-Structure Infections. PharmacoEconomics 27:5, 421-430
CrossRef295
M. Li, B. A. Diep, A. E. Villaruz, K. R. Braughton, X. Jiang, F. R. DeLeo, H. F. Chambers, Y. Lu, M. Otto. (2009) From the Cover: Evolution of virulence in epidemic community-associated methicillin-resistant Staphylococcus aureus. Proceedings of the National Academy of Sciences 106:14, 5883-5888
CrossRef296
Chukuka S. Enwemeka, Deborah Williams, Sombiri K. Enwemeka, Steve Hollosi, David Yens. (2009) Blue 470-nm Light Kills Methicillin-Resistant Staphylococcus aureus (MRSA) in Vitro. Photomedicine and Laser Surgery 27:2, 221-226
CrossRef297
Ivan Reva, Wataru Higuchi, Tomomi Takano, Olga Singur, Kyoko Ozaki, Hirokazu Isobe, Shizuka Yabe, Kohei Saito, Tatiana Baranovich, Symaa Enany, Taketo Otsuka, Vladimir Potapov, Akihito Nishiyama, Tatsuo Yamamoto. (2009) A rapid screening method for Panton-Valentine leucocidin-positive community-acquired methicillin-resistant Staphylococcus aureus belonging to multilocus sequence type 30 and its related clone using a combination of multiplex PCR and pulsed-field gel electrophoresis. Journal of Infection and Chemotherapy 15:2, 75-83
CrossRef298
J. O. Robinson, J. C. Pearson, K. J. Christiansen, G. W. Coombs, R. J. Murray. (2009) Community-associated versus healthcare-associated methicillin-resistant Staphylococcus aureus bacteraemia: a 10-year retrospective review. European Journal of Clinical Microbiology & Infectious Diseases 28:4, 353-361
CrossRef299
Heather L. Evans, Robert G. Sawyer. (2009) Preventing Bacterial Resistance in Surgical Patients. Surgical Clinics of North America 89:2, 501-519
CrossRef300
Michael Otto. (2009) Understanding the epidemic of community-associated MRSA and finding a cure: are we asking the right questions?. Expert Review of Anti-infective Therapy 7:2, 141-143
CrossRef301
Kevin W McConeghy, Dennis J Mikolich, Kerry L LaPlante. (2009) Agents for the Decolonization of Methicillin-Resistant Staphylococcus aureus. Pharmacotherapy 29:3, 263-280
CrossRef302
P. E. Pertel, B. I. Eisenstein, A. S. Link, B. Donfrid, E. J. A. Biermann, P. Bernardo, W. J. Martone. (2009) The efficacy and safety of daptomycin vs. vancomycin for the treatment of cellulitis and erysipelas. International Journal of Clinical Practice 63:3, 368-375
CrossRef303
Breena R. Taira, Adam J. Singer, Henry C. Thode, Christopher C. Lee. (2009) National epidemiology of cutaneous abscesses: 1996 to 2005. The American Journal of Emergency Medicine 27:3, 289-292
CrossRef304
Kwan Soo Ko, Mi Young Lee, Jin Yang Baek, Eun Kang, Hye Jin Roh, Hae Suk Cheong, Kyong Ran Peck, Hee Bok Oh, Yeong Seon Lee, Jae-Hoon Song. (2009) Meticillin-resistant Staphylococcus aureus blood isolates from the emergency department of a tertiary-care hospital in South Korea. International Journal of Antimicrobial Agents 33:3, 293-294
CrossRef305
Frank R. DeLeo, Binh An Diep, Michael Otto. (2009) Host Defense and Pathogenesis in Staphylococcus aureus Infections. Infectious Disease Clinics of North America 23:1, 17-34
CrossRef306
M. Bounthavong, D. I. Hsu, M. P. Okamoto. (2009) Cost-effectiveness analysis of linezolid vs. vancomycin in treating methicillin-resistant Staphylococcus aureus complicated skin and soft tissue infections using a decision analytic model. International Journal of Clinical Practice 63:3, 376-386
CrossRef307
R. Leclercq. (2009) Epidemiological and resistance issues in multidrug-resistant staphylococci and enterococci. Clinical Microbiology and Infection 15:3, 224-231
CrossRef308
Loren G. Miller, Sheldon L. Kaplan. (2009) Staphylococcus aureus: A Community Pathogen. Infectious Disease Clinics of North America 23:1, 35-52
CrossRef309
Rupali K. Doshi, Gopi Patel, Richard MacKay, Frances Wallach. (2009) Healthcare-associated Infections: Epidemiology, Prevention, and Therapy. Mount Sinai Journal of Medicine: A Journal of Translational and Personalized Medicine 76:1, 84-94
CrossRef310
Nelson P. Nicolasora, Mark A. Zacharek, Anurag N. Malani. (2009) Community-Acquired Methicillin-Resistant Staphylococcus aureus: An Emerging Cause of Acute Bacterial Parotitis. Southern Medical Journal 102:2, 208-210
CrossRef311
Michael P. Stevens, Michael B. Edmond. (2009) The Rising Tide: Skin and Soft Tissue Infections Due to Community-Associated Methicillin-Resistant Staphylococcus aureus. Southern Medical Journal 102:2, 121-122
CrossRef312
Dimitri M. Drekonja, Laura M. Traynor, Douglas D. DeCarolis, Kent B. Crossley, James R. Johnson. (2009) Treatment of non–life-threatening methicillin-resistant Staphylococcus aureus infections with alternative antimicrobial agents: a 2-year retrospective review. Diagnostic Microbiology and Infectious Disease 63:2, 201-207
CrossRef313
Elizabeth Tejeda-Ramirez, Majda Behani, Robert J. Leggiadro. (2009) Community-Associated Methicillin-Resistant Staphylococcal Infection in an Inner City Hospital Pediatric Inpatient Population. Southern Medical Journal 102:2, 135-138
CrossRef314
Jennifer A. Loughman, Stephanie A. Fritz, Gregory A. Storch, David A. Hunstad. (2009) Virulence Gene Expression in Human Community‐Acquired Staphylococcus aureus Infection. The Journal of Infectious Diseases 199:3, 294-301
CrossRef315
Maria Cícera Silva-Carvalho, Lenise Arneiro Teixeira, Fabienne Antunes Ferreira, Apoena Ribeiro, Bernadete Teixeira Ferreira-Carvalho, Agnes Marie Sá Figueiredo. (2009) Comparison of different methods for detecting methicillin resistance in MRSA isolates belonging to international lineages commonly isolated in the American continent. Microbiology and Immunology 53:2, 117-122
CrossRef316
Kevin L. Winthrop. 2009. Infections and Rheumatoid Arthritis: Old Bugs and New Drugs. , 379-386.
CrossRef317
Leonard B. Johnson, Jinson Jose, Farah Yousif, Joan Pawlak, Louis D. Saravolatz. (2009) Prevalence of Colonization With Community‐Associated Methicillin‐Resistant Staphylococcus aureus Among End‐Stage Renal Disease Patients and Healthcare Workers • . Infection Control and Hospital Epidemiology 30:1, 4-8
CrossRef318
Frank LoVecchio, Nicholas Perera, Lora Casanova, Mary Mulrow, Angela Pohl. (2009) Board-certified emergency physicians' treatment of skin and soft tissue infections in the community-acquired methicillin-resistant Staphylococcus aureus era. The American Journal of Emergency Medicine 27:1, 68-70
CrossRef319
Daniela Ramirez-Schrempp, David H. Dorfman, William E. Baker, Andrew S. Liteplo. (2009) Ultrasound Soft Tissue Applications in the Pediatric Emergency Department. Pediatric Emergency Care 25:1, 44-48
CrossRef320
Mukesh Patel. (2009) Community-Associated Meticillin-Resistant Staphylococcus aureus Infections. Drugs 69:6, 693-716
CrossRef321
Michael Otto. (2009) Looking toward basic science for potential drug discovery targets against community-associated MRSA. Medicinal Research Reviewsn/a-n/a
CrossRef322
Jung Hyun Kim, Eun Jung Kang, Yun Seok Jung, Min Hyeok Jeon, Tae Hyeong Kim, Hue Bong Sin, Su Jin Park, Eun Ju Choo. (2009) Two Cases of Bacteremia Caused by Community-Associated Methicillin-Resistant Staphylococcus aureus. Infection and Chemotherapy 41:1, 58
CrossRef323
Scott M. Goldstein, Heather N. Shelsta. (2009) Community-acquired Methicillin-resistant Staphylococcus aureus Periorbital Cellulitis: A Problem Here to Stay. Ophthalmic Plastic & Reconstructive Surgery 25:1, 77
CrossRef324
J.V. Hirschmann. (2009) When Antibiotics are Unnecessary. Dermatologic Clinics 27:1, 75-83
CrossRef325
Bo H. Chao, Jason M. Kidd, Alan W. Dow. (2009) Methicillin-resistant Staphylococcus aureus bacteremia due to prostatic abscess. Journal of Hospital Medicine 4:1, E9-E11
CrossRef326
Mark D. Corriere, Catherine F. Decker. (2008) MRSA: An Evolving Pathogen. Disease-a-Month 54:12, 751-755
CrossRef327
Dimitri Laddis, Hnin Khine, David L. Goldman. (2008) Fever and Rash: A Changing Landscape in the 21st Century. Clinical Pediatric Emergency Medicine 9:4, 244-249
CrossRef328
(2008) Improved Diagnosis of Tuberculosis. Infection 36:6, 509-509
CrossRef329
Pramodini Kale-Pradhan, Leonard B Johnson. (2008) Treatment and recurrence management of staphylococcal infections: community-acquired MRSA. Expert Review of Anti-infective Therapy 6:6, 909-915
CrossRef330
Somvadee Laohavaleeson, Steven L Barriere, David P Nicolau, Joseph L Kuti. (2008) Cost-Effectiveness of Telavancin versus Vancomycin for Treatment of Complicated Skin and Skin Structure Infections. Pharmacotherapy 28:12, 1471-1482
CrossRef331
Oana Dumitrescu, Olivier Dauwalder, Yves Gillet, François Vandenesch, Jérôme Etienne, Gérard Lina, Anne Tristan. (2008) Les infections communautaires à Staphylococcus aureus en pédiatrie : émergence des staphylocoques dorés résistants à la méticilline d’origine communautaire. Revue Francophone des Laboratoires 2008:407, 71-80
CrossRef332
Jared C. Inman, Mark Rowe, Michelle Ghostine, Terry Fleck. (2008) Pediatric Neck Abscesses—Changing Organisms and Empiric Therapies. The Laryngoscope 118:12, 2111-2114
CrossRef333
Chukuka S. Enwemeka, Deborah Williams, Steve Hollosi, David Yens, Sombiri K. Enwemeka. (2008) Visible 405 nm SLD light photo-destroys methicillin-resistant Staphylococcus aureus (MRSA) in vitro. Lasers in Surgery and Medicine 40:10, 734-737
CrossRef334
David K. Byers, Catherine F. Decker. (2008) The Changing Epidemiology of Methicillin-Resistant Staphylococcus aureus. Disease-a-Month 54:12, 756-762
CrossRef335
Jeffrey C. Hageman, Jean Patel, Patrick Franklin, Karen Miscavish, Linda McDougal, David Lonsway, Fazle N. Khan. (2008) Occurrence of a USA300 vancomycin-intermediate Staphylococcus aureus. Diagnostic Microbiology and Infectious Disease 62:4, 440-442
CrossRef336
Timothy J. Whitman. (2008) Community-Associated Methicillin-Resistant Staphylococcus aureus Skin and Soft Tissue Infections. Disease-a-Month 54:12, 780-786
CrossRef337
Ruud H. Deurenberg, Ellen E. Stobberingh. (2008) The evolution of Staphylococcus aureus. Infection, Genetics and Evolution 8:6, 747-763
CrossRef338
Yu-Hsiang Hsieh, Richard E Rothman, John G Bartlett, Samual Yang, Gabor D Kelen. (2008) HIV Seropositivity Predicts Longer Duration of Stay and Rehospitalization Among Nonbacteremic Febrile Injection Drug Users With Skin and Soft Tissue Infections. JAIDS Journal of Acquired Immune Deficiency Syndromes 49:4, 398-405
CrossRef339
G. Gener, A. Dupuy, M. Rouveau, J.-P. Claisse, I. Casin, L. Dubertret, P. Morel, F. Simon, M. Viguier. (2008) Dépistage systématique du portage nasal du Staphyloccocus aureus résistant à la méticilline (SARM) chez les patients hospitalisés en dermatologie : expérience de l’hôpital Saint-Louis. Annales de Dermatologie et de Vénéréologie 135:12, 815-821
CrossRef340
Catherine F. Decker. (2008) Pathogenesis of MRSA Infections. Disease-a-Month 54:12, 774-779
CrossRef341
Blaise R. Boles, Alexander R. Horswill. 2008. The Cyclization of Peptides and Proteins with Inteins. , 391-407.
CrossRef342
John A. Jernigan. (2008) Methicillin-Resistant Staphylococcus aureus Colonization Among Health Care Personnel in the Emergency Department: What Does It Tell Us?. Annals of Emergency Medicine 52:5, 534-536
CrossRef343
Brian P. Suffoletto, Eliot H. Cannon, Kaveh Ilkhanipour, Donald M. Yealy. (2008) Prevalence of Staphylococcus aureus Nasal Colonization in Emergency Department Personnel. Annals of Emergency Medicine 52:5, 529-533
CrossRef344
Raphael Saginur, Kathryn N. Suh. (2008) Staphylococcus aureus bacteraemia of unknown primary source: Where do we stand?. International Journal of Antimicrobial Agents 32, S21-S25
CrossRef345
Kristin J. Brinsley-Rainisch, Ronda L. Cochran, Michele L. Pearson. (2008) Dermatologists' perceptions and practices related to community-associated methicillin-resistant Staphylococcus aureus infections. American Journal of Infection Control 36:9, 668-671
CrossRef346
R. A. Seaton. (2008) Daptomycin: rationale and role in the management of skin and soft tissue infections. Journal of Antimicrobial Chemotherapy 62:Supplement 3, iii15-iii23
CrossRef347
L. Rand Carpenter, Marion Kainer, Amy Woron, William Schaffner, Timothy F. Jones. (2008) Methicillin-resistant Staphylococcus aureus and skin infections among personnel at a pediatric clinic. American Journal of Infection Control 36:9, 665-667
CrossRef348
Emilia Cercenado, Enrique Ruiz de Gopegui. (2008) Staphylococcus aureus resistente a la meticilina de origen comunitario. Enfermedades Infecciosas y Microbiología Clínica 26, 19-24
CrossRef349
April Bisaga, Katherine Paquette, Linda Sabatini, Elise O. Lovell. (2008) A Prevalence Study of Methicillin-Resistant Staphylococcus aureus Colonization in Emergency Department Health Care Workers. Annals of Emergency Medicine 52:5, 525-528
CrossRef350
Stephanie Pezzo, Charles M. Edwards. (2008) Community-Acquired, Methicillin-Resistant Staphylococcus aureus Osteomyelitis Secondary to a Hematogenous Source. Infectious Diseases in Clinical Practice 16:6, 398-400
CrossRef351
Brian R Keegan, Yvonne Romagosa, Robert S Kirsner. (2008) MRSA in Dermatology. Journal of Investigative Dermatology 128:11, 2566-2566
CrossRef352
S. N. Leonard, M. J. Rybak. (2008) Evaluation of vancomycin and daptomycin against methicillin-resistant Staphylococcus aureus and heterogeneously vancomycin-intermediate S. aureus in an in vitro pharmacokinetic/pharmacodynamic model with simulated endocardial vegetations. Journal of Antimicrobial Chemotherapy 63:1, 155-160
CrossRef353
William M. Nauseef. (2008) Bedeviling Details. The Journal of Infectious Diseases 198:8, 1101-1103
CrossRef354
Juliane Bubeck Wardenburg, Amy M. Palazzolo‐Ballance, Michael Otto, Olaf Schneewind, Frank R. DeLeo. (2008) Panton‐Valentine Leukocidin Is Not a Virulence Determinant in Murine Models of Community‐Associated Methicillin‐Resistant Staphylococcus aureus Disease. The Journal of Infectious Diseases 198:8, 1166-1170
CrossRef355
Hammond, Sarah P., Baden, Lindsey R., . (2008) Management of Skin and Soft-Tissue Infection — Polling Results. New England Journal of Medicine 359:15,
Full Text356
Chun-Hsing Liao, Shey-Ying Chen, Yu-Tsung Huang, Po-Ren Hsueh. (2008) Outcome of patients with meticillin-resistant Staphylococcus aureus bacteraemia at an emergency department of a medical centre in Taiwan. International Journal of Antimicrobial Agents 32:4, 326-332
CrossRef357
Marin H. Kollef, Lena M. Napolitano, Joseph S. Solomkin, Richard G. Wunderink, In‐Gyu Bae, Vance G. Fowler, Robert A. Balk, Dennis L. Stevens, James J. Rahal, Andrew F. Shorr, Peter K. Linden, Scott T. Micek. (2008) Health Care–Associated Infection (HAI): A Critical Appraisal of the Emerging Threat—Proceedings of the HAI Summit. Clinical Infectious Diseases 47:s2, S55-S99
CrossRef358
Rachel J. Gorwitz. (2008) Community-Associated Methicillin-Resistant Staphylococcus aureus. The Pediatric Infectious Disease Journal 27:10, 925-926
CrossRef359
Matthew Dryden. (2008) Complicated Skin and Soft Tissue Infections Caused by Methicillin-Resistant Staphylococcus aureus : Epidemiology, Risk Factors, and Presentation. Surgical Infections 9:s1, s3-s10
CrossRef360
David P. Calfee, Cassandra D. Salgado, David Classen, Kathleen M. Arias, Kelly Podgorny, Deverick J. Anderson, Helen Burstin, Susan E. Coffin, Erik R. Dubberke, Victoria Fraser, Dale N. Gerding, Frances A. Griffin, Peter Gross, Keith S. Kaye, Michael Klompas, Evelyn Lo, Jonas Marschall, Leonard A. Mermel, Lindsay Nicolle, David A. Pegues, Trish M. Perl, Sanjay Saint, Robert A. Weinstein, Robert Wise, Deborah S. Yokoe. (2008) Strategies to Prevent Transmission of Methicillin‐Resistant Staphylococcus aureus in AcuteCare Hospitals • . Infection Control and Hospital Epidemiology 29:S1, S62-S80
CrossRef361
Sheldon L. Kaplan. (2008) COMMENTARY: PREVENTION OF RECURRENT STAPHYLOCOCCAL INFECTIONS. The Pediatric Infectious Disease Journal 27:10, 935-937
CrossRef362
J.-B. Michel, P. J. Yeh, R. Chait, R. C. Moellering, R. Kishony. (2008) Drug interactions modulate the potential for evolution of resistance. Proceedings of the National Academy of Sciences 105:39, 14918-14923
CrossRef363
S. J. Rehm, H. Boucher, D. Levine, M. Campion, B. I. Eisenstein, G. A. Vigliani, G.R. Corey, E. Abrutyn. (2008) Daptomycin versus vancomycin plus gentamicin for treatment of bacteraemia and endocarditis due to Staphylococcus aureus: subset analysis of patients infected with methicillin-resistant isolates. Journal of Antimicrobial Chemotherapy 62:6, 1413-1421
CrossRef364
S. N. Leonard, G. W. Kaatz, L. R. Rucker, M. J. Rybak. (2008) Synergy between gemifloxacin and trimethoprim/sulfamethoxazole against community-associated methicillin-resistant Staphylococcus aureus. Journal of Antimicrobial Chemotherapy 62:6, 1305-1310
CrossRef365
(2008) Management of Skin and Soft-Tissue Infection. New England Journal of Medicine 359:10, 1063-1067
Full Text366
Irene Stafford, Jennifer Hernandez, Vanessa Laibl, Jeanne Sheffield, Scott Roberts, George Wendel. (2008) Community-Acquired Methicillin-Resistant Staphylococcus aureus Among Patients With Puerperal Mastitis Requiring Hospitalization. Obstetrics & Gynecology 112:3, 533-537
CrossRef367
Mark S. Pasternack. (2008) Decontamination strategies for MRSA-colonized patients. Current Infectious Disease Reports 10:5, 385-386
CrossRef368
L. Renwick, A. Hardie, E. K. Girvan, M. Smith, G. Leadbetter, E. Claas, D. Morrison, A. P. Gibb, J. Dave, K. E. Templeton. (2008) Detection of meticillin-resistant Staphylococcus aureus and Panton-Valentine leukocidin directly from clinical samples and the development of a multiplex assay using real-time polymerase chain reaction. European Journal of Clinical Microbiology & Infectious Diseases 27:9, 791-796
CrossRef369
D. E. Katz, K. C. Lindfield, J. N. Steenbergen, D. P. Benziger, K. J. Blackerby, A. G. Knapp, W. J. Martone. (2008) A pilot study of high-dose short duration daptomycin for the treatment of patients with complicated skin and skin structure infections caused by gram-positive bacteria. International Journal of Clinical Practice 62:9, 1455-1464
CrossRef370
Eugene Brent Kirkland, Brian B. Adams. (2008) Methicillin-resistant Staphylococcus aureus and athletes. Journal of the American Academy of Dermatology 59:3, 494-502
CrossRef371
H. Fan, N. Li, L. Wang. (2008) Three cases of community-associated meticillin-resistant Staphylococcus aureus infection in China. Journal of Medical Microbiology 57:9, 1178-1179
CrossRef372
Lucy A. Wibbenmeyer, Gerald P. Kealey, Barbara A. Latenser, Daniel J. Diekema, Ingrid M. Williams, Stacy L. Coffman, Patricia L. Winokur, Jennifer S. Kroeger, Robert W. Lewis, Loreen A. Herwaldt. (2008) Emergence of the USA300 Strain of Methicillin-Resistant Staphylococcus aureus in a Burn-Trauma Unit. Journal of Burn Care & Research 29:5, 790-797
CrossRef373
Andrea Ries Thurman, Tiffany M. Satterfield, David E. Soper. (2008) Methicillin-Resistant Staphylococcus aureus as a Common Cause of Vulvar Abscesses. Obstetrics & Gynecology 112:3, 538-544
CrossRef374
Chang-Teng Wu, Jainn-Jin Lin, Shao-Hsuan Hsia. (2008) Cutaneous pustular manifestations associated with disseminated septic embolism due to a Panton-Valentine leukocidin-producing strain of community-acquired methicillin-resistant Staphylococcus aureus. International Journal of Dermatology 47:9, 942-943
CrossRef375
Oana Dumitrescu, Anne Tristan, Hélène Meugnier, Michèle Bes, Manolo Gouy, Jerome Etienne, Gérard Lina, François Vandenesch. (2008) Polymorphism of the Staphylococcus aureus Panton‐Valentine Leukocidin Genes and Its Possible Link with the Fitness of Community‐Associated Methicillin‐Resistant S. aureus. The Journal of Infectious Diseases 198:5, 792-794
CrossRef376
Samer Fahmy, Michael Yacoub, Louis D. Saravolatz. (2008) Community-Acquired Methicillin-Resistant Staphylococcus aureus USA 300 Genotype Causing Pyomyositis and Kikuchi-Fujimoto Disease. Infectious Diseases in Clinical Practice 16:5, 321-323
CrossRef377
Michael H. Catenacci, Kaira King. (2008) Severe Sepsis and Septic Shock: Improving Outcomes in the Emergency Department. Emergency Medicine Clinics of North America 26:3, 603-623
CrossRef378
(2008) Antibiotic Overuse: The Influence of Social Norms. Journal of the American College of Surgeons 207:2, 265-275
CrossRef379
Do Kyung Lee, Jae Ung Hwang, Eun Hye Baek, Kang Oh Lee, Kyung Jae Kim, Nam Joo Ha. (2008) New antimicrobial drug resistance and epidemiological typing patterns of Staphylococci from clinical isolates and raw meats. Archives of Pharmacal Research 31:8, 1016-1022
CrossRef380
Binh An Diep, Michael Otto. (2008) The role of virulence determinants in community-associated MRSA pathogenesis. Trends in Microbiology 16:8, 361-369
CrossRef381
Esteban C Nannini, Martin E Stryjewski. (2008) A new lipoglycopeptide: telavancin. Expert Opinion on Pharmacotherapy 9:12, 2197-2207
CrossRef382
Rupak Datta, Susan S. Huang. (2008) Risk of Infection and Death due to Methicillin‐Resistant Staphylococcus aureus in Long‐Term Carriers. Clinical Infectious Diseases 47:2, 176-181
CrossRef383
J. A. Otter, G. L. French. (2008) The emergence of community-associated methicillin-resistant Staphylococcus aureus at a London teaching hospital, 2000–2006. Clinical Microbiology and Infection 14:7, 670-676
CrossRef384
Fredrick M. Abrahamian, Peter M. DeBlieux, Charles L. Emerman, Marin H. Kollef, Eric Kupersmith, Kenneth V. Leeper, David L. Paterson, Andrew F. Shorr. (2008) Health care–associated pneumonia: identification and initial management in the ED. The American Journal of Emergency Medicine 26:6, 1-11
CrossRef385
Brian K. Shedek, Eric James Nilles. (2008) Community-associated methicillin-resistant Staphylococcus aureus pyomyositis complicated by compartment syndrome in an immunocompetent young woman. The American Journal of Emergency Medicine 26:6, 737.e3-737.e4
CrossRef386
Pak-Leung Ho, Shuk-Kwan Chuang, Yu-Fai Choi, Rodney A. Lee, Albert C.H. Lit, Tak-Keung Ng, Tak-Lun Que, Kam-Chuen Shek, Hon-Kuan Tong, Cindy W.S. Tse, Wai-Kit Tung, Raymond W.H. Yung. (2008) Community-associated methicillin-resistant and methicillin-sensitive Staphylococcus aureus: skin and soft tissue infections in Hong Kong. Diagnostic Microbiology and Infectious Disease 61:3, 245-250
CrossRef387
Jacob J. Rauchwerger, Gregg H. Zoarski, Romanth Waghmarae, Ronald P. Rabinowitz, Joel L. Kent, Enslin F. Aldrich, Carey Walter F. Closson. (2008) Epidural Abscess Due to Spinal Cord Stimulator Trial. Pain Practice 8:4, 324-328
CrossRef388
Gary E. Stein, Sharon L. Schooley, Daniel H. Havlichek, David E. Nix. (2008) Outpatient Intravenous Antibiotic Therapy Compared With Oral Linezolid in Patients With Skin and Soft Tissue Infections. Infectious Diseases in Clinical Practice 16:4, 235-239
CrossRef389
D. T. Bearden, G. P. Allen, J. M. Christensen. (2008) Comparative in vitro activities of topical wound care products against community-associated methicillin-resistant Staphylococcus aureus. Journal of Antimicrobial Chemotherapy 62:4, 769-772
CrossRef390
Steven Y. C. Tong, Malcolm I. McDonald, Deborah C. Holt, Bart J. Currie. (2008) Global Implications of the Emergence of Community‐Associated Methicillin‐Resistant Staphylococcus aureus in Indigenous Populations. Clinical Infectious Diseases 46:12, 1871-1878
CrossRef391
Emilia Cercenado, Oscar Cuevas, Mercedes Marín, Emilio Bouza, Pilar Trincado, Teresa Boquete, Belén Padilla, Ana Vindel. (2008) Community-acquired methicillin-resistant Staphylococcus aureus in Madrid, Spain: transcontinental importation and polyclonal emergence of Panton–Valentine leukocidin-positive isolates. Diagnostic Microbiology and Infectious Disease 61:2, 143-149
CrossRef392
Edina Avdic, Sara E Cosgrove. (2008) Management and control strategies for community-associated methicillin-resistant Staphylococcus aureus. Expert Opinion on Pharmacotherapy 9:9, 1463-1479
CrossRef393
N Graue, A Korber, EN Schmid, PM Rath, J Dissemond. (2008) Therapy-resistant skin and soft tissue infections caused by community-acquired methicillin-resistant Staphylococcus aureus in a young immunocompetent adult. Journal of the European Academy of Dermatology and Venereology 22:6, 766-767
CrossRef394
George Sakoulas, Robert C. Moellering, Jr.. (2008) Increasing Antibiotic Resistance among Methicillin‐Resistant Staphylococcus aureus Strains. Clinical Infectious Diseases 46:S5, S360-S367
CrossRef395
Adolfo C Fernandez-Obregon, Dhrumil Shah, Amanda I Howell, Imane Tiyal Bentahar, Lester Carrodeguas, Arifa Siddiqui, Julia A Ejiogu. (2008) Challenges in anti-infective therapy for skin conditions: part 1. Expert Review of Dermatology 3:3, 367-394
CrossRef396
Martin E. Stryjewski, Donald R. Graham, Samuel E. Wilson, William O’Riordan, David Young, Arnold Lentnek, Douglas P. Ross, Vance G. Fowler, Alan Hopkins, H. David Friedland, Steven L. Barriere, Michael M. Kitt, G. Ralph Corey, . (2008) Telavancin Versus Vancomycin for the Treatment of Complicated Skin and Skin‐Structure Infections Caused by Gram‐Positive Organisms. Clinical Infectious Diseases 46:11, 1683-1693
CrossRef397
Martin E. Stryjewski, Henry F. Chambers. (2008) Skin and Soft‐Tissue Infections Caused by Community‐Acquired Methicillin‐Resistant Staphylococcus aureus. Clinical Infectious Diseases 46:S5, S368-S377
CrossRef398
Helen W. Boucher, G. Ralph Corey. (2008) Epidemiology of Methicillin‐Resistant Staphylococcus aureus. Clinical Infectious Diseases 46:S5, S344-S349
CrossRef399
Georgios Kalambokis, Areti Theodorou, Paraskevi Kosta, Epameinondas V. Tsianos. (2008) Multiple myeloma presenting with pyomyositis caused by community-acquired methicillin-resistant Staphylococcus aureus: report of a case and literature review. International Journal of Hematology 87:5, 516-519
CrossRef400
Binh An Diep, Gregory G. Stone, Li Basuino, Christopher J. Graber, Alita Miller, Shelley‐Ann des Etages, Alison Jones, Amy M. Palazzolo‐Ballance, Françoise Perdreau‐Remington, George F. Sensabaugh, Frank R. DeLeo, Henry F. Chambers. (2008) The Arginine Catabolic Mobile Element and Staphylococcal Chromosomal Cassette mec Linkage: Convergence of Virulence and Resistance in the USA300 Clone of Methicillin‐Resistant Staphylococcus aureus. The Journal of Infectious Diseases 197:11, 1523-1530
CrossRef401
J Patrick Powell, Richard P Wenzel. (2008) Antibiotic options for treating community-acquired MRSA. Expert Review of Anti-infective Therapy 6:3, 299-307
CrossRef402
Rachel J. Gordon, Franklin D. Lowy. (2008) Pathogenesis of Methicillin‐Resistant Staphylococcus aureus Infection. Clinical Infectious Diseases 46:S5, S350-S359
CrossRef403
S. Monecke, L. Jatzwauk, S. Weber, P. Slickers, R. Ehricht. (2008) DNA microarray-based genotyping of methicillin-resistant Staphylococcus aureus strains from Eastern Saxony. Clinical Microbiology and Infection 14:6, 534-545
CrossRef404
Catherine Liu, Christopher J. Graber, Michael Karr, Binh An Diep, Li Basuino, Brian S. Schwartz, Mark C. Enright, Simon J. O’Hanlon, Jonathon C. Thomas, Francoise Perdreau‐Remington, Shelley Gordon, Helen Gunthorpe, Richard Jacobs, Peter Jensen, Gifford Leoung, James S. Rumack, Henry F. Chambers. (2008) A Population‐Based Study of the Incidence and Molecular Epidemiology of Methicillin‐Resistant Staphylococcus aureus Disease in San Francisco, 2004–2005. Clinical Infectious Diseases 46:11, 1637-1646
CrossRef405
Jon W. Schrock, Sara Laskey, Rita K. Cydulka. (2008) Predicting observation unit treatment failures in patients with skin and soft tissue infections. International Journal of Emergency Medicine 1:2, 85-90
CrossRef406
Steven R. Feldman, Quirina M. Vallejos, Lara E. Whalley, Sara A. Quandt, Thanh Brooks, Gonzalo Cabral, Patricia Earp, Werner Bischoff, Thomas A. Arcury. (2008) Blistering Eruption in a Latino Migrant Farmworker. Journal of Agromedicine 12:4, 81-85
CrossRef407
T. Hubiche, D. Duchemin, P. Lehours, F. Boralevi, A. Taïeb, C. Léauté-Labrèze. (2008) Incidence des Staphylococcus aureus résistants à la méticilline dans les infections cutanées de l’enfant survenues en milieu communautaire : étude rétrospective 2000–2005. Annales de Dermatologie et de Vénéréologie 135:5, 361-365
CrossRef408
M. Rathore. (2008) Mother-to-child Transmission of MRSA Unlikely Cause of Neonatal Infection. AAP Grand Rounds 19:5, 58-58
CrossRef409
Michael Z. David, Daniel Glikman, Susan E. Crawford, Jie Peng, Kimberly J. King, Mark A. Hostetler, Susan Boyle‐Vavra, Robert S. Daum. (2008) What Is Community‐Associated Methicillin‐Resistant Staphylococcus aureus?. The Journal of Infectious Diseases 197:9, 1235-1243
CrossRef410
Diana Hans, Erin Kelly, Krista Wilhelmson, Eric D. Katz. (2008) Rapidly Fatal Infections. Emergency Medicine Clinics of North America 26:2, 259-279
CrossRef411
Rachel J. Gorwitz, Deanna Kruszon‐Moran, Sigrid K. McAllister, Geraldine McQuillan, Linda K. McDougal, Gregory E. Fosheim, Bette J. Jensen, George Killgore, Fred C. Tenover, Matthew J. Kuehnert. (2008) Changes in the Prevalence of Nasal Colonization with Staphylococcus aureus in the United States, 2001–2004. The Journal of Infectious Diseases 197:9, 1226-1234
CrossRef412
Thomas R. Wallin, H. Gene Hern, Bradley W. Frazee. (2008) Community-Associated Methicillin-Resistant Staphylococcus aureus. Emergency Medicine Clinics of North America 26:2, 431-455
CrossRef413
Karl J. Madaras-Kelly, Richard E. Remington, Catherine M. Oliphant, Kevin L. Sloan, David T. Bearden. (2008) Efficacy of Oral β-Lactam versus Non-β-Lactam Treatment of Uncomplicated Cellulitis. The American Journal of Medicine 121:5, 419-425
CrossRef414
Bruce M. Lo, Eleanor A. Erwin. (2008) Missed epidural brain abscess after furunculosis. The American Journal of Emergency Medicine 26:4, 522.e3-522.e4
CrossRef415
Neil Flynn, Stuart H. Cohen. (2008) The Continuing Saga of MRSA. The Journal of Infectious Diseases 197:9, 1217-1219
CrossRef416
Nesrene S. Omar, Mamdouh R. El-Nahas, Jim Gray. (2008) Novel antibiotics for the management of diabetic foot infections. International Journal of Antimicrobial Agents 31:5, 411-419
CrossRef417
Kyle J. Popovich, Bala Hota. (2008) Treatment and prevention of community-associated methicillin-resistant Staphylococcus aureus skin and soft tissue infections. Dermatologic Therapy 21:3, 167-179
CrossRef418
Jesús Rodríguez-Baño, Cornelia Bischofberger, Francisco Álvarez-Lerma, Ángel Asensio, Teresa Delgado, Dolores García-Arcal, Lola García-Ortega, M.ª Jesús Hernández, Jesús Molina-Cabrillana, Carmen Pérez-Canosa, Miquel Pujol. (2008) Vigilancia y control de Staphylococcus aureus resistente a meticilina en hospitales españoles. Documento de consenso GEIH-SEIMC y SEMPSPH. Enfermedades Infecciosas y Microbiología Clínica 26:5, 285-298
CrossRef419
Graeme R. Nimmo, Geoffrey W. Coombs. (2008) Community-associated methicillin-resistant Staphylococcus aureus (MRSA) in Australia. International Journal of Antimicrobial Agents 31:5, 401-410
CrossRef420
Stanley C. Deresinski. (2008) The efficacy and safety of ceftobiprole in the treatment of complicated skin and skin structure infections: evidence from 2 clinical trials. Diagnostic Microbiology and Infectious Disease 61:1, 103-109
CrossRef421
Y. Carmeli. (2008) Strategies for managing today’s infections. Clinical Microbiology and Infection 14:s3, 22-31
CrossRef422
A. Manzur, A. M. Dominguez, M. Pujol, M. P. M. González, E. Limon, A. Hornero, R. Martín, F. Gudiol, J. Ariza. (2008) Community-acquired methicillin-resistant Staphylococcus aureus infections: an emerging threat in Spain. Clinical Microbiology and Infection 14:4, 377-380
CrossRef423
Hsin Huang, Stuart H. Cohen, Jeff H. King, Caroline Monchaud, Hien Nguyen, Neil M. Flynn. (2008) Injecting drug use and community-associated methicillin-resistant Staphylococcus aureus infection. Diagnostic Microbiology and Infectious Disease 60:4, 347-350
CrossRef424
J. Chastre. (2008) Evolving problems with resistant pathogens. Clinical Microbiology and Infection 14:s3, 3-14
CrossRef425
E. J. C. Goldstein, D. M. Citron, Y. A. Warren, K. L. Tyrrell, M. J. Rybak. (2008) Virulence characteristics of community-associated Staphylococcus aureus and in vitro activities of moxifloxacin alone and in combination against community-associated and healthcare-associated meticillin-resistant and -susceptible S. aureus. Journal of Medical Microbiology 57:4, 452-456
CrossRef426
Tyler K Nygaard, Frank R DeLeo, Jovanka M Voyich. (2008) Community-associated methicillin-resistant Staphylococcus aureus skin infections: advances toward identifying the key virulence factors. Current Opinion in Infectious Diseases 21:2, 147-152
CrossRef427
Philippe Bernard. (2008) Management of common bacterial infections of the skin. Current Opinion in Infectious Diseases 21:2, 122-128
CrossRef428
Jacqueline M. O'Brien, Pamela K. Greenhouse, Jason J. Schafer, Carol Ann Wheeler, Ann Titus, Raymond E. Pontzer, Martin M. O'Neill, Debra Wolf. (2008) Implementing and improving the efficiency of a methicillin-resistant Staphylococcus aureus active surveillance program using information technology. American Journal of Infection Control 36:3, S62-S66
CrossRef429
Robert C. Moellering, Jr.. (2008) Current Treatment Options for Community‐Acquired Methicillin‐Resistant Staphylococcus aureus Infection. Clinical Infectious Diseases 46:7, 1032-1037
CrossRef430
Emilia Cercenado, Javier Garau, Benito Almirante, José Ramón Azanza, Rafael Cantón, Ramón Cisterna, José María Eiros, Carmen Fariñas, Jesús Fortún, Francisco Gudiol, José Mensa, Jerónimo Pachón, Álvaro Pascual, José Luis Pérez, Alejandro Rodríguez, Miguel Sánchez, Jordi Vila. (2008) Update on bacterial pathogens: virulence and resistance. Enfermedades Infecciosas y Microbiología Clínica 26, 3-21
CrossRef431
Steven N Leonard, Michael J Rybak. (2008) Telavancin: An Antimicrobial with a Multifunctional Mechanism of Action for the Treatment of Serious Gram-Positive Infections. Pharmacotherapy 28:4, 458-468
CrossRef432
C. Kieffer, B. Cribier, G. Prevost, Y. Piemont, D. Lipsker. (2008) Les souches de Staphylococcus aureus méticilline-résistant communautaires en consultation externe hospitalière de dermatologie. Annales de Dermatologie et de Vénéréologie 135:4, 263-270
CrossRef433
Paul B Cornia, Heather L Davidson, Benjamin A Lipsky. (2008) The evaluation and treatment of complicated skin and skin structure infections. Expert Opinion on Pharmacotherapy 9:5, 717-730
CrossRef434
K. J. Popovich, R. A. Weinstein, B. Hota. (2008) Are Community-Associated Methicillin-Resistant Staphylococcus aureus (MRSA) Strains Replacing Traditional Nosocomial MRSA Strains?. Clinical Infectious Diseases 46:6, 787-794
CrossRef435
J.-L. Wang, S.-Y. Chen, J.-T. Wang, G. H.-M. Wu, W.-C. Chiang, P.-R. Hsueh, Y.-C. Chen, S.-C. Chang. (2008) Comparison of Both Clinical Features and Mortality Risk Associated with Bacteremia due to Community-Acquired Methicillin-Resistant Staphylococcus aureus and Methicillin-Susceptible S. aureus. Clinical Infectious Diseases 46:6, 799-806
CrossRef436
J. M. Boyce. (2008) Community-Associated Methicillin-Resistant Staphylococcus aureus as a Cause of Health Care--Associated Infection. Clinical Infectious Diseases 46:6, 795-798
CrossRef437
Michelle K. Mendyk. (2008) Community-Associated MRSA. The Nurse Practitioner 33:3, 26-32
CrossRef438
David A. Talan, Gregory J. Moran, Fredrick M. Abrahamian. (2008) Severe Sepsis and Septic Shock in the Emergency Department. Infectious Disease Clinics of North America 22:1, 1-31
CrossRef439
Fredrick M. Abrahamian, David A. Talan, Gregory J. Moran. (2008) Management of Skin and Soft-Tissue Infections in the Emergency Department. Infectious Disease Clinics of North America 22:1, 89-116
CrossRef440
Gregory J. Moran, David A. Talan, Fredrick M. Abrahamian. (2008) Diagnosis and Management of Pneumonia in the Emergency Department. Infectious Disease Clinics of North America 22:1, 53-72
CrossRef441
G. J. Noel, K. Bush, P. Bagchi, J. Ianus, R. S. Strauss. (2008) A Randomized, Double-Blind Trial Comparing Ceftobiprole Medocaril with Vancomycin plus Ceftazidime for the Treatment of Patients with Complicated Skin and Skin-Structure Infections. Clinical Infectious Diseases 46:5, 647-655
CrossRef442
Maryn McKenna. (2008) The Many Faces of MRSA: Community-Acquired Infection Knows No Bounds. Annals of Emergency Medicine 51:3, 285-288
CrossRef443
F. C. Tenover. (2008) Vancomycin-Resistant Staphylococcus aureus: A Perfect but Geographically Limited Storm?. Clinical Infectious Diseases 46:5, 675-677
CrossRef444
David A. Talan. (2008) MRSA: Deadly Super Bug or Just Another Staph?. Annals of Emergency Medicine 51:3, 299-302
CrossRef445
B. I. Eisenstein. (2008) Treatment challenges in the management of complicated skin and soft-tissue infections. Clinical Microbiology and Infection 14, 17-25
CrossRef446
Nelson Nicolasora, Daniel R. Kaul. (2008) Infectious Disease Emergencies. Medical Clinics of North America 92:2, 427-441
CrossRef447
A. F. Widmer. (2008) Ceftobiprole: A New Option for Treatment of Skin and Soft-Tissue Infections due to Methicillin-Resistant Staphylococcus aureus. Clinical Infectious Diseases 46:5, 656-658
CrossRef448
Louis B. Rice, John G. Bartlett, Donald E. Craven, Dennis L. Stevens, Robert C. Moellering, George M. Eliopoulos. (2008) Emerging Treatments for Resistant Bacterial Infections and Pathogen-Focused Therapy. Infectious Diseases in Clinical Practice 16:Suppl. 1, S1-S20
CrossRef449
Daniel J. Pallin, Daniel J. Egan, Andrea J. Pelletier, Janice A. Espinola, David C. Hooper, Carlos A. Camargo. (2008) Increased US Emergency Department Visits for Skin and Soft Tissue Infections, and Changes in Antibiotic Choices, During the Emergence of Community-Associated Methicillin-Resistant Staphylococcus aureus. Annals of Emergency Medicine 51:3, 291-298
CrossRef450
L. G. Miller, B. A. Diep. (2008) Colonization, Fomites, and Virulence: Rethinking the Pathogenesis of Community-Associated Methicillin-Resistant Staphylococcus aureus Infection. Clinical Infectious Diseases 46:5, 752-760
CrossRef451
Gregory J. Moran, David A. Talan, Fredrick M. Abrahamian. (2008) Antimicrobial Prophylaxis for Wounds and Procedures in the Emergency Department. Infectious Disease Clinics of North America 22:1, 117-143
CrossRef452
L. D. Saravolatz, M. Billeter, M. J. Zervos, A. Y. Chen, J. R. Dalovisio, C. Kurukularatne. (2008) Dalbavancin: a Novel Once-Weekly Lipoglycopeptide Antibiotic. Clinical Infectious Diseases 46:4, 577-583
CrossRef453
L. B. Rice. (2008) The Maxwell Finland Lecture: For the Duration-- Rational Antibiotic Administration in an Era of Antimicrobial Resistance and Clostridium difficile. Clinical Infectious Diseases 46:4, 491-496
CrossRef454
E. J. C. Goldstein, R. A. Proctor. (2008) Role of Folate Antagonists in the Treatment of Methicillin-Resistant Staphylococcus aureus Infection. Clinical Infectious Diseases 46:4, 584-593
CrossRef455
F. R. DeLeo, M. Otto. (2008) An antidote for Staphylococcus aureus pneumonia?. Journal of Experimental Medicine 205:2, 271-274
CrossRef456
(2008) Super bugs: super problems. International Journal of Dental Hygiene 6:1, 72-73
CrossRef457
Michael W Ellis. (2008) Is antimicrobial therapy needed to manage uncomplicated skin and soft-tissue abscesses?. Expert Review of Anti-infective Therapy 6:1, 9-13
CrossRef458
Brendan J. Kilbane, Sally L. Reynolds. (2008) Emergency Department Management of Community-Acquired Methicillin-Resistant Staphylococcus aureus. Pediatric Emergency Care 24:2, 109-114
CrossRef459
A. D. Kennedy, M. Otto, K. R. Braughton, A. R. Whitney, L. Chen, B. Mathema, J. R. Mediavilla, K. A. Byrne, L. D. Parkins, F. C. Tenover, B. N. Kreiswirth, J. M. Musser, F. R. DeLeo. (2008) From the Cover: Epidemic community-associated methicillin-resistant Staphylococcus aureus: Recent clonal expansion and diversification. Proceedings of the National Academy of Sciences 105:4, 1327-1332
CrossRef460
Joseph F. John, Jr.,, Jodi A. Lindsay. (2008) Clones and Drones: Do Variants of Panton‐Valentine Leukocidin Extend the Reach of Community‐Associated Methicillin‐Resistant Staphylococcus aureus ?. The Journal of Infectious Diseases 197:2, 175-178
CrossRef461
F. Patrick O’Hara, Nicolas Guex, J. Michael Word, Linda A. Miller, Julie A. Becker, Stacey L. Walsh, Nicole E. Scangarella, Joshua M. West, Ribhi M. Shawar, Heather Amrine‐Madsen. (2008) A Geographic Variant of the Staphylococcus aureus Panton‐Valentine Leukocidin Toxin and the Origin of Community‐Associated Methicillin‐Resistant S. aureus USA300. The Journal of Infectious Diseases 197:2, 187-194
CrossRef462
B. Spellberg, R. Guidos, D. Gilbert, J. Bradley, H. W. Boucher, W. M. Scheld, J. G. Bartlett, J. Edwards, . (2008) The Epidemic of Antibiotic-Resistant Infections: A Call to Action for the Medical Community from the Infectious Diseases Society of America. Clinical Infectious Diseases 46:2, 155-164
CrossRef463
Rachel J. Gorwitz. (2008) Understanding the Success of Methicillin‐Resistant Staphylococcus aureus Strains Causing Epidemic Disease in the Community. The Journal of Infectious Diseases 197:2, 179-182
CrossRef464
Michael Otto. (2008) Targeted Immunotherapy for Staphylococcal Infections. BioDrugs 22:1, 27-36
CrossRef465
Carlos Pigrau, José Barberán. (2008) Infecciones de piel y partes blandas por grampositivos multirresistentes. Enfermedades Infecciosas y Microbiología Clínica 26, 21-30
CrossRef466
Hae-Kyung Park, So-Youn Woo, Yun-Jae Jung, Eun Ok Lee, Je-Eun Cha, Hye-Sook Park, Seung-Joo Lee. (2008) Detection of Virulence Genes of Staphyloccus aureus and Staphylococcus epidermidis Isolated from Suprapubic Urine from Infants with Fever. Journal of Bacteriology and Virology 38:4, 189
CrossRef467
Rachel J. Gorwitz. (2008) A Review of Community-Associated Methicillin-Resistant Staphylococcus aureus Skin and Soft Tissue Infections. The Pediatric Infectious Disease Journal 27:1, 1-7
CrossRef468
Carlos Pigrau Serrallach, Emilio Pérez-Trallero. (2008) Infecciones por grampositivos: ¿necesitamos nuevos agentes antimicrobianos?. Enfermedades Infecciosas y Microbiología Clínica 26, 1-3
CrossRef469
Curtis L. Cetrulo, Travis Shiba, Michael T. Friel, Brian Davis, Rudolph F. Buntic, Gregory M. Buncke, Darrell Brooks. (2008) Management of exposed total knee prostheses with microvascular tissue transfer. Microsurgery 28:8, 617-622
CrossRef470
P. Bernard, V. Jarlier, A. Santerre-Henriksen. (2008) Sensibilité aux antibiotiques des souches de Staphylococcus aureus responsables d’infections cutanées communautaires. Annales de Dermatologie et de Vénéréologie 135:1, 13-19
CrossRef471
Sarah P. Hammond, Lindsey R. Baden. (2008) Antibiotic prophylaxis for patients with acute leukemia. Leukemia & Lymphoma 49:2, 183-193
CrossRef472
Susan E. Crawford, Robert S. Daum. 2008. Bacterial Pneumonia, Lung Abscess, and Empyema. , 501-553.
CrossRef473
Richard S. Vetter, Geoffrey K. Isbister. (2008) Medical Aspects of Spider Bites. Annual Review of Entomology 53:1, 409-429
CrossRef474
James Q. Boedicker, Liang Li, Timothy R. Kline, Rustem F. Ismagilov. (2008) Detecting bacteria and determining their susceptibility to antibiotics by stochastic confinement in nanoliter droplets using plug-based microfluidics. Lab on a Chip 8:8, 1265
CrossRef475
Armando Paez, Daniel Skiest. (2008) Methicillin-resistant Staphylococcus aureus: From the hospital to the community. Current Infectious Disease Reports 10:1, 14-21
CrossRef476
Ljiljana Petrovic-Jeremic, Nada Kuljic-Kapulica, Veljko Mirovic, Branislava Kocic. (2008) Staphylococcus aureus methicillin-resistance mechanisms. Vojnosanitetski pregled 65:5, 377-382
CrossRef477
A. J. Kallen, J. Hageman, R. Gorwitz, S. E. Beekmann, P. M. Polgreen. (2007) Characteristics of Staphylococcus aureus Community-Acquired Pneumonia during the 2006-2007 Influenza Season. Clinical Infectious Diseases 45:12, 1655-1655
CrossRef478
S. M. Hamilton, A. E. Bryant, K. C. Carroll, V. Lockary, Y. Ma, E. McIndoo, L. G. Miller, F. Perdreau-Remington, J. Pullman, G. F. Risi, D. B. Salmi, D. L. Stevens. (2007) In Vitro Production of Panton-Valentine Leukocidin among Strains of Methicillin-Resistant Staphylococcus aureus Causing Diverse Infections. Clinical Infectious Diseases 45:12, 1550-1558
CrossRef479
Timothy C. Lee, Matthew M. Carrick, Bradford G. Scott, Joseph C. Hodges, Hoang Q. Pham. (2007) Incidence and clinical characteristics of methicillin-resistant Staphylococcus aureus necrotizing fasciitis in a large urban hospital. The American Journal of Surgery 194:6, 809-813
CrossRef480
Franklin D Lowy. (2007) Secrets of a superbug. Nature Medicine 13:12, 1418-1420
CrossRef481
Michael R Jacobs. (2007) Retapamulin: a semisynthetic pleuromutilin compound for topical treatment of skin infections in adults and children. Future Microbiology 2:6, 591-600
CrossRef482
Knut Ohlsen, Udo Lorenz. (2007) Novel targets for antibiotics in Staphylococcus aureus. Future Microbiology 2:6, 655-666
CrossRef483
S. Monecke, P. Slickers, M. J. Ellington, A. M. Kearns, R. Ehricht. (2007) High diversity of Panton-Valentine leukocidin-positive, methicillin-susceptible isolates of Staphylococcus aureus and implications for the evolution of community-associated methicillin-resistant S. aureus. Clinical Microbiology and Infection 13:12, 1157-1164
CrossRef484
Rong Wang, Kevin R Braughton, Dorothee Kretschmer, Thanh-Huy L Bach, Shu Y Queck, Min Li, Adam D Kennedy, David W Dorward, Seymour J Klebanoff, Andreas Peschel, Frank R DeLeo, Michael Otto. (2007) Identification of novel cytolytic peptides as key virulence determinants for community-associated MRSA. Nature Medicine 13:12, 1510-1514
CrossRef485
Michelle L. McCaskill, Edward O. Mason, Sheldon L. Kaplan, Wendy Hammerman, Linda B. Lamberth, Kristina G. Hultén. (2007) Increase of the USA300 Clone Among Community-Acquired Methicillin-Susceptible Staphylococcus aureus Causing Invasive Infections. The Pediatric Infectious Disease Journal 26:12, 1122-1127
CrossRef486
Susan L Davis, Peggy S McKinnon, Levi M Hall, George Delgado, Warren Rose, Robert F Wilson, Michael J Rybak. (2007) Daptomycin versus Vancomycin for Complicated Skin and Skin Structure Infections: Clinical and Economic Outcomes. Pharmacotherapy 27:12, 1611-1618
CrossRef487
F. Durupt, L. Mayor, M. Bes, M.-E. Reverdy, F. Vandenesch, L. Thomas, J. Etienne. (2007) Prevalence of Staphylococcus aureus toxins and nasal carriage in furuncles and impetigo. British Journal of Dermatology 157:6, 1161-1167
CrossRef488
Ilker Uçkay, Stephan Harbarth, Didier Pittet. (2007) Management of Gram-positive bacteraemia. Current Opinion in Infectious Diseases 20:6, 561-567
CrossRef489
Cindy A Loffler, Conan MacDougall. (2007) Update on prevalence and treatment of methicillin-resistant Staphylococcus aureus infections. Expert Review of Anti-infective Therapy 5:6, 961-981
CrossRef490
Min Li, David J. Cha, Yuping Lai, Amer E. Villaruz, Daniel E. Sturdevant, Michael Otto. (2007) The antimicrobial peptide-sensing system aps of Staphylococcus aureus. Molecular Microbiology 66:5, 1136-1147
CrossRef491
Heather C. Yun, Michael W. Ellis, James H. Jorgensen. (2007) Activity of ceftobiprole against community-associated methicillin-resistant Staphylococcus aureus isolates recently recovered from US military trainees. Diagnostic Microbiology and Infectious Disease 59:4, 463-466
CrossRef492
Fitch, Michael T., Manthey, David E., McGinnis, Henderson D., Nicks, Bret A., Pariyadath, Manoj, . (2007) Abscess Incision and Drainage. New England Journal of Medicine 357:19,
Full Text493
Barry I Eisenstein. (2007) Use of daptomycin for treatment of Staphylococcus aureus infections. Expert Opinion on Drug Discovery 2:11, 1523-1536
CrossRef494
Benjamin A. Lipsky, John A. Weigelt, Vikas Gupta, Aaron Killian, Michael M. Peng. (2007) Skin, Soft Tissue, Bone, and Joint Infections in Hospitalized Patients: Epidemiology and Microbiological, Clinical, and Economic Outcomes • . Infection Control and Hospital Epidemiology 28:11, 1290-1298
CrossRef495
G. A. Noskin, R. J. Rubin, J. J. Schentag, J. Kluytmans, E. C. Hedblom, C. Jacobson, M. Smulders, E. Gemmen, M. Bharmal. (2007) National Trends in Staphylococcus aureus Infection Rates: Impact on Economic Burden and Mortality over a 6-Year Period (1998-2003). Clinical Infectious Diseases 45:9, 1132-1140
CrossRef496
Robert C. Moellering, John R. Graybill, John E. McGowan, Lawrence Corey. (2007) Antimicrobial resistance prevention initiative—an update: Proceedings of an expert panel on resistance. American Journal of Infection Control 35:9, S1-S23
CrossRef497
Apoena Ribeiro, Amada Zambrana Coronado, Maria Cícera Silva-Carvalho, Bernadete Teixeira Ferreira-Carvalho, Cícero Dias, Ronaldo Rozenbaum, Pedro Fernandez Del Peloso, Cassiana da Costa Ferreira Leite, Lenise Arneiro Teixeira, Agnes Marie Sá Figueiredo. (2007) Detection and characterization of international community-acquired infections by methicillin-resistant Staphylococcus aureus clones in Rio de Janeiro and Porto Alegre cities causing both community- and hospital-associated diseases. Diagnostic Microbiology and Infectious Disease 59:3, 339-345
CrossRef498
C. D. Sifri, J. Park, G. A. Helm, M. E. Stemper, S. K. Shukla. (2007) Fatal Brain Abscess due to Community-Associated Methicillin-Resistant Staphylococcus aureus Strain USA300. Clinical Infectious Diseases 45:9, e113-e117
CrossRef499
Bruno Dohin, Yves Gillet, Rémi Kohler, Gérard Lina, François Vandenesch, Philippe Vanhems, Daniel Floret, Jerome Etienne. (2007) Pediatric Bone and Joint Infections Caused by Panton-Valentine Leukocidin-Positive Staphylococcus aureus. The Pediatric Infectious Disease Journal 26:11, 1042-1048
CrossRef500
Bradley W. Frazee. (2007) Commentary. Annals of Emergency Medicine 50:5, 614-616
CrossRef501
Michael Otto. (2007) Antibodies to Block Staph Virulence. Chemistry & Biology 14:10, 1093-1094
CrossRef502
Herminia de Lencastre, Duarte Oliveira, Alexander Tomasz. (2007) Antibiotic resistant Staphylococcus aureus: a paradigm of adaptive power. Current Opinion in Microbiology 10:5, 428-435
CrossRef503
Traci L. Hedrick, Philip W. Smith, Leo M. Gazoni, Robert G. Sawyer. (2007) The Appropriate Use of Antibiotics in Surgery: A Review of Surgical Infections. Current Problems in Surgery 44:10, 635-675
CrossRef504
A. F. Shorr. (2007) Epidemiology of Staphylococcal Resistance. Clinical Infectious Diseases 45:Supplement 3, S171-S176
CrossRef505
Jillian M. Szczesiul, Kenneth M. Shermock, Umbreen Idrees Murtaza, George K. Siberry. (2007) NO DECREASE IN CLINDAMYCIN SUSCEPTIBILITY DESPITE INCREASED USE OF CLINDAMYCIN FOR PEDIATRIC COMMUNITY-ASSOCIATED METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS SKIN INFECTIONS. The Pediatric Infectious Disease Journal 26:9, 852-854
CrossRef506
Jake E. Krige, Kimberly Lindfield, Lawrence Friedrich, Constance Otradovec, William J. Martone, David E. Katz, Frank Tally. (2007) Effectiveness and duration of daptomycin therapy in resolving clinical symptoms in the treatment of complicated skin and skin structure infections*. Current Medical Research and Opinion 23:9, 2147-2156
CrossRef507
Fredrick M. Abrahamian, Eric W. Snyder. (2007) Community-associated methicillin-resistant Staphylococcus aureus: Incidence, clinical presentation, and treatment decisions. Current Infectious Disease Reports 9:5, 391-397
CrossRef508
Susan Tofte. (2007) Atopic Dermatitis. Nursing Clinics of North America 42:3, 407-419
CrossRef509
Richard P. Wenzel, Gonzalo Bearman, Michael B. Edmond. (2007) Community-acquired methicillin-resistant Staphylococcus aureus (MRSA): new issues for infection control. International Journal of Antimicrobial Agents 30:3, 210-212
CrossRef510
E. Yoko Furuya, Heather A. Cook, Mei-Ho Lee, Maureen Miller, Elaine Larson, Sandra Hyman, Phyllis Della-Latta, Eneida A. Mendonca, Franklin D. Lowy. (2007) Community-associated methicillin-resistant Staphylococcus aureus prevalence: How common is it? A methodological comparison of prevalence ascertainment. American Journal of Infection Control 35:6, 359-366
CrossRef511
GB Zore, V Awad, AD Thakre, UK Halde, NS Meshram, BS Surwase, S Mohan Karuppayil. (2007) Activity-directed fractionation and isolation of four antibacterial compounds from Abrus precatorius L. roots. Natural Product Research 21:10, 933-940
CrossRef512
Daum, Robert S., . (2007) Skin and Soft-Tissue Infections Caused by Methicillin-Resistant Staphylococcus aureus. New England Journal of Medicine 357:4, 380-390
Full Text513
G. B. Zore, V. Awad, A. D. Thakre, U. K. Halde, N. S. Meshram, B. S. Surwase, S. Mohan Karuppayil. (2007) Activity-directed-fractionation and isolation of four antibacterial compounds from Abrus precatorius L., roots. Natural Product Research 21:9, 838-845
CrossRef514
Mark A. Kosinski, Warren S. Joseph. (2007) Update on the Treatment of Diabetic Foot Infections. Clinics in Podiatric Medicine and Surgery 24:3, 383-396
CrossRef515
Abigail Hankin, Worth W. Everett. (2007) Are Antibiotics Necessary After Incision and Drainage of a Cutaneous Abscess?. Annals of Emergency Medicine 50:1, 49-51
CrossRef516
Fredrick M. Abrahamian, Sunil D. Shroff. (2007) Use of Routine Wound Cultures to Evaluate Cutaneous Abscesses for Community-Associated Methicillin-Resistant Staphylococcus Aureus. Annals of Emergency Medicine 50:1, 66-67
CrossRef517
Robert C. Moellering, John R. Graybill, John E. McGowan, Lawrence Corey. (2007) Antimicrobial Resistance Prevention Initiative—An Update: Proceedings of an Expert Panel on Resistance. The American Journal of Medicine 120:7, S4-S25
CrossRef518
Thomas P Lodise, Peggy S McKinnon. (2007) Burden of Methicillin-Resistant Staphylococcus aureus : Focus on Clinical and Economic Outcomes. Pharmacotherapy 27:7, 1001-1012
CrossRef519
Katherine L. Heilpern. (2007) Skin and Soft Tissue Abscesses: The Case for Culturing Abscess Fluid. Annals of Emergency Medicine 50:1, 64-66
CrossRef520
Irena L. Kenneley. (2007) Infection Control and Prevention in Home Healthcare. Home Healthcare Nurse: The Journal for the Home Care and Hospice Professional 25:7, 459-469
CrossRef521
Thomas R. Talbot, Joseph J. Nania, Patty W. Wright, Ian Jones, Dominik Aronsky. (2007) Evaluation of the Microbiology of Soft‐Tissue Abscesses in the Era of Community‐Associated Strains of Methicillin‐Resistant Staphylococcus aureus: An Argument for Empirical Contact Precautions • . Infection Control and Hospital Epidemiology 28:6, 730-732
CrossRef522
Annalisa Pantosti, Andrea Sanchini, Monica Monaco. (2007) Mechanisms of antibiotic resistance in Staphylococcus aureus. Future Microbiology 2:3, 323-334
CrossRef523
C. D. Stack, L. D. Sanchez, C. Fischer, C. Rosen, D. McGillicuddy, R. Wolfe, J. Edlow, P. Rosen. (2007) Community-acquired methicillin-resistant Staphylococcus aureus cellulitis. Internal and Emergency Medicine 2:2, 137-139
CrossRef524
Joel Guss, Ken Kazahaya. (2007) Antibiotic-resistant Staphylococcus aureus in community-acquired pediatric neck abscesses. International Journal of Pediatric Otorhinolaryngology 71:6, 943-948
CrossRef525
Henry F Chambers, Sharath S Hegde. (2007) Combating the growing problem of methicillin-resistant Staphylococcus aureus : do the newer antibiotics represent a better alternative to vancomycin?. Expert Review of Anti-infective Therapy 5:3, 333-335
CrossRef526
Alan Forrest, George L. Drusano. 2007. Modeling of Toxicities Due to Antibiotics. , 449-462.
CrossRef527
Richard S. Vetter, David L. Swanson. (2007) Of spiders and zebras: Publication of inadequately documented loxoscelism case reports. Journal of the American Academy of Dermatology 56:6, 1063-1064
CrossRef528
Sarah P. Hammond, Lindsey R. Baden. (2007) Antibiotic prophylaxis during chemotherapy-induced neutropenia for patients with acute leukemia. Current Hematologic Malignancy Reports 2:2, 97-103
CrossRef529
Aryun Kim, Joseph L Kuti, David P Nicolau. (2007) Review of dalbavancin, a novel semisynthetic lipoglycopeptide. Expert Opinion on Investigational Drugs 16:5, 717-733
CrossRef530
C. Sola, H. A. Saka, A. Vindel, J. L. Bocco, . (2007) High frequency of Panton-Valentine leukocidin genes in invasive methicillin-susceptible Staphylococcus aureus strains and the relationship with methicillin-resistant Staphylococcus aureus in Córdoba, Argentina. European Journal of Clinical Microbiology & Infectious Diseases 26:4, 281-286
CrossRef531
P. Del Giudice, V. Blanc, J. Étienne. (2007) Les infections à Staphylococcus aureus résistants en ville : les dermatologues en première ligne !. Annales de Dermatologie et de Vénéréologie 134:4, 317-320
CrossRef532
Patrice Francois, David Hernandez, Jacques Schrenzel. (2007) Genome content determination in methicillin-resistant Staphylococcus aureus. Future Microbiology 2:2, 187-198
CrossRef533
John S. Steinberg, Paul J. Kim, Mark R. Abbruzzese. (2007) An Infectious Disease Update on Antibiotics: Emerging Resistance. Clinics in Podiatric Medicine and Surgery 24:2, 285-309
CrossRef534
Marion Gabillot-Carré, Jean-Claude Roujeau. (2007) Acute bacterial skin infections and cellulitis. Current Opinion in Infectious Diseases 20:2, 118-123
CrossRef535
J. J. Ruhe, N. Smith, R. W. Bradsher, A. Menon. (2007) Community-Onset Methicillin-Resistant Staphylococcus aureus Skin and Soft-Tissue Infections: Impact of Antimicrobial Therapy on Outcome. Clinical Infectious Diseases 44:6, 777-784
CrossRef536
R. J. Gorwitz. (2007) The Role of Ancillary Antimicrobial Therapy for Treatment of Uncomplicated Skin Infections in the Era of Community-Associated Methicillin-Resistant Staphylococcus aureus. Clinical Infectious Diseases 44:6, 785-787
CrossRef537
Traci A. Takahashi, Amy Baernstein, Ingrid Binswanger, Katharine Bradley, Joseph O. Merrill. (2007) Predictors of Hospitalization for Injection Drug Users Seeking Care for Soft Tissue Infections. Journal of General Internal Medicine 22:3, 382-388
CrossRef538
Michael R. Jacobs, Ronald N. Jones, Philip A. Giordano. (2007) Oral β-lactams applied to uncomplicated infections of skin and skin structures. Diagnostic Microbiology and Infectious Disease 57:3, S55-S65
CrossRef539
Deverick J. Anderson, Daniel J. Sexton. (2007) Infection Control and Hospital Epidemiology. Infectious Diseases in Clinical Practice 15:2, 113-115
CrossRef540
Somvadee Laohavaleeson, Joseph L Kuti, David P Nicolau. (2007) Telavancin: a novel lipoglycopeptide for serious Gram-positive infections. Expert Opinion on Investigational Drugs 16:3, 347-357
CrossRef541
Stephen G. Weber, Susan S. Huang, Shannon Oriola, W. Charles Huskins, Gary A. Noskin, Kathleen Harriman, Russell N. Olmsted, Marc Bonten, Tammy Lundstrom, Michael W. Climo, Mary‐Claire Roghmann, Cathryn L. Murphy, Tobi B. Karchmer. (2007) Legislative Mandates for Use of Active Surveillance Cultures to Screen for Methicillin‐Resistant Staphylococcus aureus and Vancomycin‐Resistant Enterococci: Position Statement From the Joint SHEA and APIC Task Force • . Infection Control and Hospital Epidemiology 28:3, 249-260
CrossRef542
Emma J Bishop, Benjamin P Howden. (2007) Treatment of Staphylococcus aureus infections: new issues, emerging therapies and future directions. Expert Opinion on Emerging Drugs 12:1, 1-22
CrossRef543
Sally F. Bloomfield, Barry Cookson, Fred Falkiner, Chris Griffith, Vivien Cleary. (2007) Methicillin-resistant Staphylococcus aureus, Clostridium difficile, and extended-spectrum β-lactamase–producing Escherichia coli in the community: Assessing the problem and controlling the spread. American Journal of Infection Control 35:2, 86-88
CrossRef544
Stephen G. Weber, Susan S. Huang, Shannon Oriola, W. Charles Huskins, Gary A. Noskin, Kathleen Harriman, Russell N. Olmsted, Marc Bonten, Tammy Lundstrom, Michael W. Climo, Mary-Claire Roghmann, Cathryn L. Murphy, Tobi B. Karchmer. (2007) Legislative mandates for use of active surveillance cultures to screen for methicillin-resistant Staphylococcus aureus and vancomycin-resistant enterococci: Position statement from the Joint SHEA and APIC Task Force. American Journal of Infection Control 35:2, 73-85
CrossRef545
Elijah Paintsil. (2007) Pediatric community-acquired methicillin-resistant Staphylococcus aureus infection and colonization: trends and management. Current Opinion in Pediatrics 19:1, 75-82
CrossRef546
Jodi A Lindsay. (2007) Prospects for a MRSA vaccine. Future Microbiology 2:1, 1-3
CrossRef547
Bradley N. Younggren, Mark Denny. (2007) Emergency Management of Difficult Wounds: Part II. Emergency Medicine Clinics of North America 25:1, 123-134
CrossRef548
Yoko Nakamura, Mohamud Daya. (2007) Use of Appropriate Antimicrobials in Wound Management. Emergency Medicine Clinics of North America 25:1, 159-176
CrossRef549
Chisho Hoshino, Noriyuki Satoh, Shinichi Sugawara, Chizuko Kuriyama, Akio Kikuchi, Masahiro Ohta. (2007) Community-Acquired Staphylococcus aureus Pneumonia Accompanied by Rapidly Progressive Glomerulonephritis and Hemophagocytic Syndrome. Internal Medicine 46:13, 1047-1053
CrossRef550
David J. Karras, Wayne A. Satz, Jeffrey Barrett. 2007. Management of Infectious Diseases. , 63-71.
CrossRef551
Susan Boyle-Vavra, Robert S Daum. (2007) Community-acquired methicillin-resistant Staphylococcus aureus: the role of Panton–Valentine leukocidin. Laboratory Investigation 87:1, 3-9
CrossRef552
Sang Taek Heo, Kyong Ran Peck, Seong Yeol Ryu, Ki Tae Kwon, Kwan Soo Ko, Won Sup Oh, Nam Yong Lee, Jae-Hoon Song. (2007) Analysis of Methicillin Resistance among Staphylococcus aureus Blood Isolates in an Emergency Department. Journal of Korean Medical Science 22:4, 682
CrossRef553
D.R. Snydman. (2007) Methicillin-Resistant S. aureus Infections among Patients in the Emergency Department. Yearbook of Medicine 2007, 67-68
CrossRef554
B.H. Thiers. (2007) Methicillin-Resistant S. aureus Infections among Patients in the Emergency Department. Yearbook of Dermatology and Dermatologic Surgery 2007, 123-124
CrossRef555
Jae-Seok Kim, Jeong-Su Park, Wonkeun Song, Han-Sung Kim, Hyoun Chan Cho, Kyu Man Lee, Eui-Chong Kim. (2007) Panton-Valentine Leukocidin Positive Staphylococcus aureus Isolated from Blood in Korea. The Korean Journal of Laboratory Medicine 27:4, 286
CrossRef556
Andrew F Shorr. (2007) Epidemiology and Economic Impact??of Meticillin-Resistant Staphylococcus aureus. PharmacoEconomics 25:9, 751-768
CrossRef557
Prabhavathi Fernandes. (2006) Antibacterial discovery and development—the failure of success?. Nature Biotechnology 24:12, 1497-1503
CrossRef558
Fred A. Lopez, Serge Lartchenko. (2006) Skin and Soft Tissue Infections. Infectious Disease Clinics of North America 20:4, 759-772
CrossRef559
William J. Martone, Kenneth C. Lamp. (2006) Efficacy of daptomycin in complicated skin and skin-structure infections due to methicillin-sensitive and ‐resistant Staphylococcus aureus : results from the CORE Registry*. Current Medical Research and Opinion 22:12, 2337-2343
CrossRef560
Susan I Gerber. (2006) Describing the methicillin-resistant Staphylococcus aureus epidemic: a public health challenge. Expert Review of Anti-infective Therapy 4:6, 905-907
CrossRef561
M. S. Helfand, R. A. Bonomo. (2006) Extended-Spectrum -Lactamases in Multidrug-Resistant Escherichia coli: Changing the Therapy for Hospital-Acquired and Community-Acquired Infections. Clinical Infectious Diseases 43:11, 1415-1416
CrossRef562
(2006) Therapy for Methicillin-Resistant Staphylococcus aureus. New England Journal of Medicine 355:20, 2153-2155
Full Text563
Robert N. Hensinger. (2006) Impending Danger. Journal of Pediatric Orthopaedics 26:6, 701-702
CrossRef564
Heiman FL Wertheim, Henri A Verbrugh. (2006) Global prevalence of meticillin-resistant Staphylococcus aureus. The Lancet 368:9550, 1866
CrossRef565
Shelby Scott. (2006) Medical Report. ACSM's Health & Fitness Journal 10:6, 33-35
CrossRef566
Grayson, M. Lindsay, . (2006) The Treatment Triangle for Staphylococcal Infections. New England Journal of Medicine 355:7, 724-727
Full Text
- Letters
